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ABSTRACT 
 
DNA and Peptide Functionalized Gold Nanoparticles 
for Biological Imaging and Transfection 
By 
Ziyan Zhang 
 
Doctor of Philosophy in Chemistry 
Washington University in St. Louis, 2011 
Professor John-Stephen A. Taylor, Chair 
 
This dissertation focuses on the development of DNA and peptide functionalized 
gold nanoparticles. Three nanoparticle systems have been developed: (1) nucleic acid-
directed self-assembly of a gold nanoparticle PET imaging agent; (2) cationic peptide 
functionalized gold nanoparticles; (3) gold nanoparticle templated peptide nanoshells. 
The first functionalized gold nanoparticles were constructed by assembling ODN 
(oligodeoxynucleotide)-derivatized gold nanoparticles with functionalized 
complementary PNAs (peptide nucleic acids). The PNAs were conjugated with DOTA 
for chelating chelating 64Cu for PET imaging, PEG for conferring stealth properties, and 
Cy5 for fluorescent imaging. The resulting functionalized nanoparticles showed good 
stability both in vitro and in vivo and had biodistribution properties expected for a 
PEGylated gold nanoparticle rather than that for the functionalized PNAs used in the 
construction.  
! iii!
The second nanoparticle system was arginine-rich peptide and lysine-rich peptide 
functionalized cationic gold nanoparticles as transfection agents. A series of cysteine 
containing oligoarginine was synthesized by automated solid phase Fmoc synthesis. 
chloroauric acid was reduced in the presence of the peptides. The resulting gold 
nanoparticles were around 13 nm in diameter with zeta potential around 29 mV. Compare 
to other reported cationic gold nanoparticles, the arginine-rich gold nanoparticles were 
highly stable in up to 0.6 M NaCl solutions and up to pH 8.5 in non-phosphate containing 
buffers. In phosphate buffers, however, the nanoparticles started to aggregate at above pH 
6, though aggregation was reversible by lowering the pH. The strong affinity between 
arginine and phosphate groups also resulted in the nanoparticle’s strong ODN binding 
ability. Despite of the reported cytotoxicity of oligoarginines, the arginine-rich gold 
nanoparticles showed no cytotoxicity even at a very high concentration. An improved 
assembly approach was also investigated. Cationic peptides were exchanged with 
cetyltrimethylammonium bromide (CTAB) on gold nanoparticles fabricated by seeded 
growth method. This approach allowed quick assembly of a library of different peptide 
on the gold surface. The approach was validated by synthesizing three cationic gold 
nanoparticles, R13C-AuNP, K10Y2C-AuNP and R13C/K10Y2C-AuNP. All of the 
nanoparticles retained the monodispersity of the original CTABAuNP colloid. Their 
stability and ODN binding ability showed distinct difference due to their different surface 
composition. All of the colloids were proved to be non-toxic at high concentration but 
further optimization is needed in the transfection efficiency. 
The third nanoparticle system was developed based on the ligand exchange 
approach. A cysteine containing lysine-rich peptide was deposited on CTABAuNP. 
! iv!
Then the lysines were crosslinked by a biodegradable crosslinker, Sulfo-EGS (Ethylene 
glycol bis[sulfosuccinimidylsuccinate]), at various peptide/crosslinker ratio. The gold 
core was then removed by potassium cyanide. The resulting peptide nanoshells were 
about 40 nm in diameter, compare to the 15 nm diameter before the gold core was 
removed. Crosslinking also resulted in dramatic decrease of the ODN binding ability of 
the nanoparticle and the nanoshells. This approach showed great potential of making a 
combinatorial library of biodegradable nanostructures quickly for a broad range of 
applications. 
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Chapter 1 
 
An Introduction to Biomolecule Modified Gold Nanoparticles   
1.1 Nanoparticles 
Nanotechnology involves structures in the sub-micrometer, or more typically, 1-
100nm dimensions. This scale is much smaller than what is studied in conventional 
material science, which is several microns and above. And yet it is quite large compare to 
that investigated by traditional physicists and chemists, who study atoms and bonds at the 
angstrom level (Figure 1.1). Modern physics has found that materials in this range 
exhibit unique properties, different from both the bulk material and the molecules and 
atoms that they are composed of. These properties include decreased melting temperature 
[1], color (Figure 1.2), quantum confinement in semiconductor particles (Figure 1.3), 
surface plasmon resonance in some metal particles and superparamagnetism in magnetic 
materials [2], etc. These properties provide unique opportunities in material science, 
making nanoparticles highly desirable candidates as novel catalysts, paints, lubricants, 
optical devices, etc.  
 
 
Figure 1.1. The scale of some common structures 
19
Figure 1.1. Chart depicting the length scale of some common structures.
synthetic methodologies, surface analytical techniques, and materials fabrication methods
exist for building monodisperse nanostructures of many compositions and shapes in very
high yields. Wet-chemical techniques [9, 10] are still extensively used but in addition other
methods, such as hard template directed [11, 12, 13, 14], lithographic [15, 16, 17], and
vapor phase [18, 19] syntheses, have been developed. These strategies are being used to
create isotropic nanoparticles as well as novel anisotropic nanostructures, such as disks
[20, 21, 22], prisms [23, 24, 25, 26], cubes [27, 28, 29], rods [11, 12, 13, 14, 30,
31, 32, 33, 34], wires [11, 12, 13, 14, 35], and branched structures [34, 36, 37, 38]
(Figure 1.2). These nanomaterials are typically composed of noble metals as well as
semiconducting and polymeric materials.
Nanomaterials are ideal for the study of the physical and chemical consequences of
miniaturization, or the changes that arise in bulk materials as they are scaled down to
clusters that consist of tens to thousands of atoms [5, 6, 7, 8]. In the nanoscale size
regime, materials have very large surface-to-volume ratios and high surface energies and,
unlike in any other size regime, the chemical and physical properties of materials are
highly dependent upon their size, shape, and composition [4]. These e↵ects are found
Human hair Viruses Nanoparticles Glucose moleculeGrain of sand Atoms
2 
 
 
Figure 1.2 The diameter of gold nanoparticles determines the wavelengths 
of light absorbed. The colors in this diagram illustrate this effect. 
(Copyright © Nanotechnology eLearning Center) 
 
 
 
Figure 1.3 Fluorescent properties of nanosized semiconductor due to 
quantum confinement effect (quantum dots). The top picture was shot in 
ultraviolet light and the bottom was shot in ambient light. The length of 
the synthesis reaction determines particle size for CdSe, increasing from 
left to right. (Copyright © The University of Wisconsin-Madison 
Materials Research Science and Engineering Center) 
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The special size range and large surface to volume of nanoparticles not only 
results in interesting physical behaviors that benefit material industry, but also enables 
biomedical scientists to develop novel diagnostic and therapeutic agents. First of all, the 
intercellular space between renal blood vessel epithelial cells is on the scale of 1-10 nm. 
For this reason, small molecule drugs usually have very limited blood retention and are 
cleared through the kidneys within the first hour or even a few minutes after 
administration. To compensate, large doses or repetitive administration of small molecule 
drugs are usually used, which can create serious side effects and high expense. In 
contrast, nanoparticles (usually above 10 nm) can easily bypass renal clearance and are 
usually cleared through mononuclear phagocytic system (MPS). If the surface of the 
nanoparticles are appropriately modified, blood retention can be greatly extended, from 
several hours to days [3]. For targeted nanoparticles, this property provides longer time 
for the targeting ligands to interact with the target site and hence increase specificity. For 
oncology applications, this property allows the nanoparticles with a therapeutic payload 
to take full advantage of the enhanced permeation and retention (EPR) effect. Secondly, 
the large surface area allows multiple drugs as well as different functional groups to be 
attached to one single nanoparticle. One nanoparticle can carry hundreds to hundreds of 
thousands of functional groups on the surface. This enables the particle to carry contrast 
agents for different imaging techniques, like MRI/optical imaging [4], PET/MRI imaging 
[5], etc. These multimodal approaches combine the advantages of multiple imaging 
techniques such as high resolution, quick data acquisition, low dosage and easy 
application, and achieve results that are difficult if not impossible to achieve through any 
single technique. One single particle may also carry multiple copies of targeting moieties 
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to enhance specificity and facilitate delivery. Ligands that bind specifically with surface 
receptor on the targeted cells were incorporated in the nanoparticles, such as RGD 
peptide [6],  tumor necrosis factor-alpha (TNF-alpha) [7, 8], aptamers [9], etc. Similar to 
the multimodal nanoparticle imaging agents, some nanoparticles also carry several kinds 
of targeting ligands that bind to different receptors on same type of cells[10]. The 
simultaneous binding greatly enhanced the binding affinity and specificity to a level that 
can hardly be achieved by any single ligand. 
 
1.2 Gold Nanoparticles 
Among all the nanomaterials, pseudo-spherical gold nanoparticles (AuNP) are 
one of the most widely studied. For many centuries, people have recognized the distinct 
properties of gold nanoparticles apart from the bulk material and have used the “soluble 
gold” as components in medicinal remedies and, due to their astonishing red color, as 
dyes and pigments in architecture and art (Figure 1.4). 
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Figure 1.4 Lycurgus Cup, a Roman glass cage cup crafted in 4th to 5th 
century B. C. The cup showed ruby red color in transmitted light (left 
panel) and green color in reflected light (right panel) due to the colloid 
silver-gold alloy (about 70nm) dispersed in the glass. [11] (Copyright © 
Johnbod from Wikipedia) 
 
Modern research rediscovered gold nanoparticles’ unique physical properties, 
which have become the basis of advanced applications in many fields. The deep-red color 
of gold nanoparticle colloids in water and glasses reflects the surface plasmon band 
(SPB), a broad absorption band in the visible region around 520 nm. The SPB is due to 
the coherent oscillation of an electron gas in the conduction band at the surface of the 
nanoparticles (the 6s shell of the conduction band for gold nanoparticles) in response to 
the oscillating electromagnetic field of the incoming light [12]. Because the surface 
plasmon band is very sensitive to the distribution of electrons on the particle surface, the 
study of the SPB has remained an area of very active research from both a scientific and 
technological standpoint.  The SPB of gold nanoparticle is affected by surface ligands, 
the distance between the nanoparticles, the particle sizes, etc. Thus, the SPB has become 
a sensitive and reliable reporter of surface modification, interactions, aggregation, and 
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particle growth. As a result, gold nanoparticles have been used to probe antibody-antigen 
[13, 14] and nucleic acid interactions [15].  
 
1.2.1 The Photothermal Effect 
The photothermal effect is also derived from surface plasmon resonance. When 
the surface electrons on the nanoparticles oscillate in resonance with the incoming light, 
part of the energy from the photons is transferred to heat and generates a fast and highly 
localized thermal effect. Modern lithography uses noble metal nanoparticles to form 
high-resolution patterns that cannot be achieved by conventional methods. When a laser 
beam shines on the substrate, the exposed noble metal nanoparticles will generate enough 
heat to melt or degrade the surrounding polymers. Because the photothermal effect is 
very fast and highly localized, the pattern can be precisely controlled by the laser beam. 
The most important application of the photothermal effect in the biomedical field is to 
use noble nanoparticles, especially gold nanoparticles, to thermally destroy tumor tissue. 
The excitation wavelength of the SPB is largely determined by the size and geometry of 
the nanoparticle. Unfortunately, the SPB of spherical gold nanoparticles fall between 
510-570 nm which is outside the optimal window for tissue penetration of 700-900 nm. It 
wasn’t until Cathy Murphy of University of Illinois discovered how to make gold 
nanorods that useful biological applications of the photothermal effect were possible. 
While the axial SPR peaks of a nanorod remain at 500 nm, the longitudinal SPR peak can 
range from 500 nm to 1000 nm by adjusting the aspect ratio [16].  
El-Sayed and co-workers found that they were able to achieve destruction of 
cancer cells by the photothermal effect with gold nanorods which are preferably 
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internalized with a laser power that is low enough to be safe for normal cells [17]. In their 
recent studies using a mouse model [18], the nanorods were conjugated to mPEG-SH 
5000 and injected into mice both intravenously and subcutaneously. Using the 
transmission imaging of the NIR (near infrared) laser with a customized camera, the 
tumor could be well visualized after nanorod accumulation following either intravenous 
or subcutaneous injections. After exposure to a CW red laser at 808 nm with an energy of 
1 W cm-2 for 10 min, tumor volumes in both delivery methods did not grow while the 
untreated tumor kept growing at a rapid rate. The intravenous treated tumors show lower 
photothermal therapy efficiency due to lower amount of gold nanorods inside the tumor. 
 
1.2.2 Fluorescence Modulation  
Fluorescence modulation is another important physical property of gold 
nanoparticles. When a fluorophore is placed at a relatively short distance, e.g., within 10 
nm, from a metal particle possessing a strong plasmon field, the electrons of the 
flurophore participating in the excitation/emission interacts with the plasmon field. The 
interaction results in either quenching or enhancement of the fluorescence emission 
intensity level. Establishing the relationship between the plasmon field and the resulting 
fluorescence intensity level can be beneficial in developing highly efficacious optical 
contrast agents for bio-sensing and imaging. Schneider and co workers studied the 
distance dependence of fluorescence quenching effect on the surface of gold 
nanoparticles with layer-by-layer assembled polyelectrolytes [19] and found that the 
quenching efficiency decreases rapidly with the increasing distance. At 1 nm from the 
surface, the quenching efficiency could reach over 90% whereas when the distance 
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increased to 3 nm, only 30% of the efficiency remained. This property provides the basis 
of many gold nanoparticle based fluorescent probes [20-22]. Interestingly, in the cases of 
certain ions, e.g. Eu3+ [23], or beyond a certain distance, the fluorescence of the 
fluorophores is greatly enhanced. Like the quenching effect, this enhancement is also 
very sensitive to changes in distance and thus provides valuable information on substance 
interactions around the gold nanoparticle. The enhancement effect, though, is less widely 
used in biological applications than the quenching effect. 
 
1.2.3 Gold NP Toxicity 
For biomedical applications, gold nanoparticles have another desirable property 
compared to other nanomaterials—low toxicity. Because of its inertness, gold has shown 
great compatibility inside the biological systems. Paciotti and coworkers showed that 
although gold nanoparticles accumulated in the mouse liver in high concentration, the 
mouse still survived without apparent harm [8]. Ligands such as CTAB and 
oligoarginines, that are known to have high cytotoxicity in their free form appeared 
harmless in high concentration once they were tightly bound to gold nanoparticle surfaces 
[24].  
 
1.2.4 Preparation of Gold NP 
Because of the desirable properties discussed above, gold nanoparticles have been 
used for medical purposes since ancient times. Historically, alchemists would make 
potions out of gold nanoparticles (“Aurum Potabile” or “potable gold”) to treat many 
diseases [25]. Rheumatoid arthritis was among the first modern conditions where gold 
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was part of the therapy [25]. The gold nanoparticles were implanted near the arthritic side 
to help relieve pain. Studies have shown that intraarticular administration of nanogold 
ameliorates the clinical course of collagen-induced arthritis (CIA) in rats [26]. Nanogold 
exerted antiangiogenic activities (inhibition of the growth of new blood vessels) and 
subsequently reduced macrophage infiltration and inflammation, which resulted in 
attenuation of arthritis [27]. In the recent years, gold nanoparticles and their properties 
have led to new and exciting developments with great potential in biology and medicine. 
Gold nanoparticles have been used as carriers for drugs like Paclitaxel [28]. Contrast 
agents have also been complexed with gold nanoparticles for cellular detect and in vivo 
tumor detection. Colloidal gold itself can be used as therapeutics in the photothermal 
therapy to destruct tumors. 
The first scientific report describing the preparation of colloidal gold 
nanoparticles appeared in 1857 when Michael Faraday found that the “fine particles” 
formed from the aqueous reduction of gold chloride by phosphorus could be further 
stabilized by the addition of carbon disulfide, giving a “beautiful ruby fluid” [29]. 
Nowadays, most colloid synthetic methods for production of gold nanoparticles follow a 
similar strategy, where solvated gold salt is reduced in the presence of surface capping 
molecules, which prevent particle aggregation by electrostatic and/or physical repulsion. 
The size of the particles is usually controlled by temperature, pH, the capping ligands, 
and most importantly, the ratio of the gold ion/reducing agent or gold ion/stabilizer, 
which smaller (and usually more monodispersed) sizes obtained from smaller ratios. 
Citrate reduction is one of the most widely used methods for obtaining gold 
nanoparticles ranging from 9 nm to 120 nm. This method was first reported by J. 
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Turkevich[30] and then further improved by G. Frens [31] and J. Kimling [32]. In this 
method, sodium citrate serves both as reducing agent and capping agent. The size of the 
gold nanoparticles is determined by the ratio between chloroauric acid and sodium citrate. 
The reduction only happens at elevated temperature (boiling point of the chloroauric acid 
solution) and results in monodispersed aqueous gold colloid with negative zeta potential. 
Sodium borohydride is another widely used reducer in making gold nanoparticles. 
Compared to sodium citrate, sodium borohydride is much stronger and can reduce the 
gold ion to gold nanoparticle at room temperature. However, sodium borohydride alone is 
a very weak capping agent. Gold nanoparticles synthesized by sodium borohydride alone 
are relatively small and polydispersed. Stronger capping agents are usually used to 
achieve a narrower size distribution. In the seeded growth method reported by Jana et al. 
[33], sodium citrate was used as capping agent while the gold ion was reduced by sodium 
borohydride at room temperature. More stable nanoparticles can be obtained by using 
thiolated ligands as capping agents during reduction. The Brust-Shiffrin method [34, 35], 
first published in 1994, utilized a two-phase system. AuCl4- is transferred to toluene using 
tetraoctylammonium bromide as the phase-transfer reagent and is reduced by sodium 
borohydride in the presence of dodecanethiol. The organic phase changes color from 
orange to deep brown within a few seconds upon addition of NaBH4. The resulting gold 
nanoparticles are capped by dodecanethiol and can be repeatedly isolated and redissolved 
in common organic solvents without irreversible aggregation or decomposition. They can 
be easily handled and functionalized just as stable organic and molecular compounds. 
Another category of gold nanoparticle synthesis is seeded growth strategy. 
Murphy’s group first reported the seeded growth approach for gold nanorod preparation 
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[36] and gold nanoparticle preparation [33]. Small roughly spherical gold seeds with a 
mean diameter between 3 and 4 nm were prepared first by NaBH4 reduction in the 
presence of citrate. Then the seeds were mixed with a growth solution containing a gold 
salt and cetyl-tri-methyl ammonium bromide (CTAB) as the capping agent and ascorbic 
acid as the reducing agent. In the preparation of gold nanorods, silver ions were also 
added for aspect ratio control. Ascorbic acid is a very weak reducing agent that can’t 
reduce goldIII to gold0 without the presence of the seeds. Therefore, nucleation is 
controlled and the growth only happens on the surface of the seeds. The size of the 
particles is mainly dependent on the gold seed to gold salt ratio.  
Various ligands have been used to stabilize gold nanoparticles in different 
synthetic strategies, such as PPh3 in the Brust-Schiffrin method [37], citrate ion in citrate 
reduction [31], tannic acetate in a modified citrate reduction method [38], centrimonium 
bromide [33] and polyethyleneimine [39]. Among all the explored ligands, sulfur-
containing ligands have proven to form the strongest bonds to the surface, due to the soft 
character of both sulfur and gold. All other ligands that are used to protect gold 
nanoparticles in the synthetic process can be replaced by sulfur-containing ligands to 
increase stability, such as in the two phase synthesis [37] and seeded growth synthesis 
[33] methods.  
 
1.2.5 Functionalization of Gold NP 
Functionalization of gold nanoparticles is usually achieved through deposition of 
thiolated ligands on the gold surface. One of the deposition strategies involves 
displacement of non-sulfur containing capping ligands with sulfur containing ligands on 
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the gold surface. This process is usually complete within 24 hours. In the preparation of 
oligodeoxynucleotide (ODN) functionalized gold nanoparticles reported by Mirkin and 
coworkers in 1996, citrate on the gold surface was displaced by thiolated ODNs 
overnight [15, 40-44]. Since thiol groups are ubiquitous among proteins, this approach is 
the most widely used method for preparing protein functionalized gold nanoparticles. 
Paciotti et al reported a tumor necrosis factor (TNF) functionalized gold nanoparticle for 
tumor targeting. The TNF was also deposited on the gold surface by displacing the citrate 
[45].  
Another strategy is to exchange the thiolated ligands used in synthetic step with 
thiolated ligands of a desired function. This method is particularly useful when the 
desired functional ligands are hydrophobic, or smaller particles are needed. This strategy 
usually takes much longer time, usually several days. If the two ligands are similar in 
solubility and sulfur containing group, a large excess of the incoming ligands is needed to 
ensure the complete exchange [46].  
Once the gold nanoparticles are stabilized by thiolated ligands, further 
functionalization can be done through the reactive groups on the ligands, such as amino 
groups, carboxyl groups, nucleotides, and alkynes. Astruc et al. reported a “clickable” 
gold nanoparticle [47]. Dodecanethiolate stabilized gold nanoparticles were first 
synthesized by the two-phase method. Then the surface dodecanethiolate was exchanged 
with bromoundecanethiol. The terminal bromide was further substituted by azido group 
using sodium azide. The resulting gold nanoparticles can be conveniently functionalized 
by acetylene bearing molecules through the classic copper catalyzed click reactions. 
Brust et. al reported the synthesis of lipase functionalized gold nanoparticle [48]. In their 
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approach, a bifunctional linker with thiol and azide on either end was directly deposited 
on the citrateAuNP. Then, acetylene modified lipase was “clicked” on the gold surface 
through a copper catalyzed click reaction. Agarose gel electrophoresis assay proved the 
success of the conjugation and a fluorometric lipase activity assay proved that the lipase 
on the gold particle still retained its enzymatic activity.  
Sulfur containing molecules are ubiquitous in biological systems. Most of the 
natural proteins contain cysteine. It is also very convenient to conjugate cysteine to a 
synthetic peptide or add a terminal thiol to synthetic oligonucleotide. People have 
fabricated gold nanoparticles with thiolated oligodeoxynucleotides (ODNs) [15, 40-44], 
peptides [43, 49, 50], antibodies [51-54], and other proteins [55, 56]. Biomolecule 
modified gold nanoparticles show excellent stability compared to individual 
biomolecules, good biocompatibility compared to other synthetic nanomaterials and 
versatile functionality compared to conventional formulation. Biomolecule modified gold 
nanoparticles are now heavily utilized in chemistry, biology, engineering, and medicine. 
 
1.3 Focus of Dissertation 
This dissertation is focused on the design, synthesis, characterization and 
application of biomolecule functionalized gold nanoparticles and its derivatives. 
Although great progress has been made in this field, the full potential of the biomolecule 
modified gold nanoparticle is far from thoroughly investigated. Rather than 
functionalizing gold nanoparticles with protein, this dissertation focuses on 
functionalization with synthetic ODNs and peptides whose primary and secondary 
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structures are easier to manipulate and thus the properties are more predictable and 
versatile.  
Chapter 2 explores a self-assembling strategy to form multifunctional gold 
nanoparticles based on Watson-Crick base paring. Since the introduction of ODN 
protected gold nanoparticles by Chad Mirkin from Northwestern University [15], much 
work has been done using this type of gold nanoparticle for in vitro gene detection and 
delivery. However, the multivalency of the ODN-AuNP hasn’t been fully utilized on 
functionalities in a broader range. In addition, no in vivo study has been done with ODN-
AuNP, therefore, its potential as delivery agent has never been explored. The work 
described in Chapter 2 demonstrates that oligodeoxynucleotide protected gold 
nanoparticles assemble readily with functionalized complementary peptide nucleic acids 
in a sequence specific manner. The hybridization yields multifunctional nanoparticles 
that are stable under physiological conditions. We also show that the non-specific cell 
uptake of gold-ODN nanoparticles can be greatly reduced by PEGylation. The resulting 
nanoparticle showed typical biodistribution pattern of gold nanoparticles. The majority of 
the particles were cleared from the blood stream by MPS system and retained in the liver 
and spleen. With improvements in circulation and the addition of targeting moieties, this 
self-assembling system could be used in development of imaging and therapeutic agents 
in the future. 
ODN protected gold nanoparticles are also used for in vitro ODN delivery [57]. 
However, this approach requires that the gold particle be designed individually for each 
payload. This approach is limited to smaller ODNs like siRNA, shRNA or antisense 
DNA but will be less efficient for larger types of genetic material like plasmid DNA due 
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to the spatial constraints of the DNA duplex.  Chapter 3 reports a library of arginine-rich 
peptide functionalized gold nanoparticles for nucleic acid delivery. Oligoarginines have 
been studied and utilized intensively for cell permeation and gene delivery due to the 
unusually high affinity between guanidinium groups and phosphate groups [58]. Many 
types of nanoparticles have been made with oligoarginines for transfection purposes [59-
63]. However, the effect of oligoarginine on gold nanoparticles has never been explored. 
It was expected that gold nanoparticles functionalized with arginine rich peptide should 
be highly stable due to the high basicity of the guanidinium group. It was also expected to 
enter the cells with high efficiency and bind to DNA with strong affinity. A library of 
cysteine containing oligoarginines were synthesized by automated solid phase Fmoc 
synthesis. The number of arginines on each strand was altered to investigate the effect of 
arginine density. Meanwhile, threonine or valine was also incorporated into some of the 
strands to optimize nanoparticle stability. A library of Arg-AuNP were synthesized 
accordingly by NaBH4 reduction. The stability, DNA binding ability, transfection 
efficiency and cytotoxicity of the cationic AuNPs (cAuNPs) were evaluated and 
compared. It was found that all the cAuNPs tested were non-toxic to the cells. AuNP-
CR13 showed the highest DNA binding affinity and stability under high salt 
concentration and high pH in non-phosphate containing buffer. All the arginine-rich 
nanoparticles were found to aggregate reversibly in high pH phosphate buffer, 
presumably due to the hydrogen bonding between guanidinium groups and phosphate 
groups. Besides direct reduction, another synthetic approach was investigated. Three 
peptide-AuNPs, R13C-AuNP, K10Y2C-AuNP and R13C/K10Y2C-AuNP, were 
synthesized through ligand-peptide exchange on gold nanoparticles fabricated by citrate 
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reduction and seeded growth method. Nanoparticles fabricated this way retained the 
morphology and monodispersity of the original gold colloid and yet showed distinct 
properties consistence with their surface composition. All the cationic gold nanoparticles 
studied in this dissertation were non-toxic to cells, however, no transfection was observed 
using any of the gold nanoparticles, which requires further investigation. 
Although numerous studies including the studies in this dissertation have shown 
that gold nanoparticles are highly tolerated in biological systems, their clearance is still a 
major concern when used systemically. This was the intrinsic drawback of gold 
nanoparticles that can’t be overcome. To be useful for nanomedicine nanoparticles must 
be biodegradable. Chapter 4 describes the construction of degradable nanoparticles 
based on a combinatorial approach that uses gold nanoparticles as templates for 
assembling a shell of crosslinked peptides after which the gold was removed. The size, 
surface properties and DNA binding ability of the nanoshells were studied. It was shown 
that crosslinked peptide nanoshells remained intact after the gold cores were removed 
although the size expands a little presumably due to inter-strand repulsion. Crosslinking 
of the peptides, however, greatly decreased the DNA binding ability of the nanoparticles, 
indicating that extra DNA binding moiety such as arginine should be incorporated into 
the peptide shell. The results in Chapter 4 demonstrate that this combinatorial approach 
can yield stable peptide-shell nanoparticles. Many parameters in this approach could be 
optimized for different applications in the future, such as particle size, peptide 
composition, peptide modification, crosslinking strength, etc.   
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This dissertation concludes with a short summary of the biomolecule 
functionalized gold nanoparticles prepared and suggestions for how this work can be 
moved forward in the future in both the fundamental and applied arenas (Chapter 5). 
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Chapter 2 
Nucleic Acid-directed Self-assembly of a Gold Nanoparticle PET 
Imaging Agent 
2.1 Introduction 
Nanotechnology offers great potential for the development of highly sensitive 
diagnostic and targeted therapeutic agents. The particular size range of 10-100 nm gives 
nanoparticles extraordinary loading capacity for therapeutics and/or contrast agents as 
well as other functions such as targeting. Mutifunctional and multimodal nanoparticles 
have been developed as MRI, PET, photoacoustic and optical imaging agents, as well as 
photodynamic, photothermal, and chemotherapeutic agents among others [1-6].  
Functionalization of nanoparticles is largely carried out by covalent bond formation using 
classical bioconjugation methods such as amide bond formation, addition or substitution 
reactions of thiols, hydrazone formation, and metal-thiol reactions, and more recently via 
various click reactions [7-10]. These strategies generally suffer from difficulty in 
controlling the extent of the reactions and in characterizing the products making it 
difficult to precisely tune the composition and properties of the nanoparticles.  In 
addition, the covalent nature of the conjugations can inhibit their biodegradation. 
Functionality has also been incorporated through weaker and less specific non-covalent 
self-assembly mechanisms such as electrostatic interactions, micelle or liposome 
formation, and host guest interactions [11-14].  Nanoparticles produced in this way, 
however, have variable stability and are less well defined.   
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A potentially more promising approach to assembling nanoparticles with 
programmable composition and properties would be to use the higher specificity and 
tunable stability afforded by nucleic acid hybridization.  Though nucleic acid 
hybridization has been extensively used for assembling materials for structural and 
analytical purposes [15-17], it has seen very little use for constructing highly 
functionalized nanoparticles for in vivo use.  Nucleic acid hybridization has been shown 
to assemble targeting agents with imaging agents in vivo for pretargeting strategies aimed 
at improving specificity [18, 19].  More recently nucleic acid hybriziation was used to 
pre-assemble PAMAM nanoparticles with antibodies for pretargeting cells in culture 
which were then recognized by a complementary radiolabeled nucleic acid [20].   We 
envision that nucleic acid hybridization could be used as a reversible click reaction to 
rapidly and combinatorially assemble more complicated NP containing any desired 
combination of targeting, imaging, therapeutic, endosome disrupting, and stealth 
functionalities (Figure 2.1).   
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Figure 2.1 Self-assembly of functionalized gold nanoparticles. Gold 
nanoparticles conjugated to thiolated ODNs are hybridized with any 
combination of functionalized PNAs to rapidly assemble a library of 
functionalized gold NP. 
 
Gold nanoparticles are an ideal platform for nucleic acid directed self-assembly 
because they can be readily produced in a variety of sizes and shapes and easily 
derivatized with thiolated oligodeoxynucleotides (ODNs) [21-24].  Instead of using a 
functionalized complementary ODN to hybridize to the ODN on the gold NP, we decided 
to make use of functionalized PNAs (peptide nucleic acid) because their unnatural 
polyamide backbone confers a number of advantages over ODNs [25, 26].  PNAs are 
highly resistant to degradation by biological systems and also protect the DNA or RNA to 
which they are bound from degradation.  They also hybridize to DNA with higher 
affinity than does DNA making it possible to use shorter nucleic acid sequences for 
assembly.  Most importantly, they can be conveniently synthesized by solid phase 
automated peptide synthesis, which allows the easy preparation of PNA-peptide hybrids 
and the incorporation of a wide variety of amino acid analogues and auxiliary agents. 
Herein, we will describe the assembly of gold nanoparticles functionalized with PEG, 
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64Cu-DOTA, and fluorescent molecules, and demonstrate that they behave like 
nanoparticles in vivo. 
 
 
Figure 2.2 Functionalized ODNs and PNAs used in this study.  All 
ODNs are written in a 5’→3’ direction and all PNAs in an amino → 
carboxy direction. 
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2.2 Results and Discussion 
2.2.1 ODN-Gold Nanoparticle Synthesis 
Citrate gold nanoparticles, citrate-AuNP, were synthesized by standard methods 
[27] and were 10.2 ± 0.8 nm in diameter as measured by TEM (Figure 2.3a).  Dynamic 
light scattering gave a very similar hydrodynamic radius of 10.3 ± 2.6 nm (Figure 2.3a).  
The particles had an expected highly negative zeta potential of -22.5 ± 2.8 mV.  
Conjugation of the gold nanoparticles to a 3’-thiolated ODN (Figure 2.2) by standard 
methods [21], gave ODN-AuNP.  TEM of a negatively stained sample showed particles 
with a diameter of about 16.1 ± 0.9 nm consisting of a dark core and a bright outer circle 
corresponding to the ODN layer (Figure 2.3b).  Dynamic light scattering gave a similar 
hydrodynamic diameter of 16.2 ± 4.1 nm (Figure 2.3b).  The thickness of the ODN 
layer was about 2.5-2.8 nm deduced from the difference in size of the ODN-AuNP and 
the citrate-AuNP from TEM and DLS experiments.  The thickness of the ODN layer is 
less than half the length of a helical 18-mer ODN (6.3 nm) indicating that the ODN is not 
fully extended on the gold surface and may be partially contacting the surface. The zeta 
potential of the ODN-AuNP increased to -31.7 ± 0.1 mV due to the large number of 
negatively charged phosphate groups contributed by the ODN.   
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Figure 2.3 TEM pictures of gold NPs at various stages of construction.  
TEM of A) Citrate-AuNP, B) ODN18-AuNP , and C) PNA15-PEG3/ 
PNA15-DOTA·ODN18-AuNP with a PNA-PEG/PNA-DOTA ratio of 3:1. 
All three samples were stained with uranyl acetate. Panel C) was 
assembled from four representative pictures. 
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Figure 2.4  Dynamic light scattering analysis of gold NP at various 
stages of construction. 
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2.2.2 Sequence Specific Self-Assembly with PNA 
Gold has been known as an effective fluorescent quencher and the fluorescent 
quenching efficiency decreases drastically as the distance between the fluorophore and 
the gold surface increases [28]. We utilized this unique property to demonstrate the 
self-assembly of the ODN-AuNP with PNA. We synthesized a 15-mer PNA that was 
labeled with Cy5 at its amino end, Cy5-PNA (Figure 2.2), which is complementary 
(antisense) to the ODN on the AuNP.  Upon PNA-ODN hybridization, the fluorophore is 
positioned three nucleotides away from the gold surface, or about one nm if the 
PNA-ODN duplex were perpendicular to the surface [29]. This distance is close enough 
to cause significant fluorescent quenching [28]. As shown in Figure 2.5, when the 
Cy5-PNA was mixed with ODN-AuNP, the fluorescence of the Cy5 was almost 
completely quenched and remained so until the concentration of the Cy5-PNA-mer was 
about 90 times the concentration of the gold nanoparticle. Beyond this point, the 
fluorescence started to increase linearly indicating that all the complementary binding 
sites on the gold NP had been saturated.  The gold NP without the ODN shell, however, 
also quenched the fluorescence of the PNA.  To demonstrate that the quenching was due 
to sequence specific binding of the PNA to the ODN shell, and not simply to the gold 
surface, a gold NP bearing the non-complementary ODN, ODNnc (Figure 2.2) was 
synthesized.  When titrated with Cy5-PNA very little quenching was observed (Figure 
2.5). 
 
 
 
 
33 
 
 
 
Figure 2.5 Fluorescence titration of ODN-AuNPs with Cy5-PNAs.  A) 
Fluorescence of increasing concentration of Cy5-PNA in presence (■) or 
absence (□) of 5 nM ODN-AuNP. B) Fluorescence of increasing 
concentration of Cy5-PNA in (♦) buffer alone, or the presence of: (Δ) 10 
nM ODN-AuNP; (▲) 10 nM ODNnc-AuNP; (■) 10 nM citrate-AuNP.  
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To determine the stability of the PNA·ODN hybrid on the gold NP, temperature 
dependent fluorescence measurements were made between room temperature and 85°C.   
Following an initial heating to 85°C to degas the sample, the fluorescent heating and 
cooling curves for ODN-AuNP·Cy5-PNA were quite reproducible and indicated that the 
complexes had a melting temperature of 67°C (Figure 2.6).  This can be compared to a 
melting temperature of 71.5 °C for ODN·Cy5-PNA determined by temperature dependent 
absorbance measurements.  
 
2.2.3 PEGylation of the ODN-Gold NP 
 For imaging specific targets in vivo it is important that the NPs are not recognized 
by the MPS (mononuclear phagocyte) system, often referred to in the literature as the 
RES (reticulo-endothelial) system, or taken up by non-target cells [30].  It has been 
found that PEGylation can greatly reduce binding of NP to proteins and confer stealth 
character [31].  To study the interaction of the PNA·ODN-AuNP with cells and the 
ability of PEGylation to reduce non-specific binding and uptake we synthesized a 
fluorescently labeled PNA for tracking the NP and a PEGylated PNA for conferring 
stealth character.  To minimize quenching of the fluorescence, Cy5 was conjugated to 
the carboxy terminus of PNA to give PNA-Cy5 (Figure 2.2) via a carboxy-terminal 
lysine group so that the fluorophore would be directed away from the surface of the gold 
NP.  To create a PEGylated PNA with sufficient PEG to cover the surface, the PNA was 
derivatized with three PEG2K molecules via acylation of three lysines at the carboxy 
terminus of PNA and spaced apart by two beta-alanines to give PNA-PEG3 (Figure 2.2).  
The ODN-AuNP was hybridized with a stoichiometric amount of PNA with differing 
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ratios of PNA-PEG3:PNA-Cy5.  TEM analysis under negative staining of 75/25 ratio of 
PNA-DOTA/PNA-PEG3·ODN-AuNP showed a dark center of about 12 nm, representing 
the gold core, surrounded by a narrower bright band than was seen with the ODN-AuNP, 
and a large and diffuse dark area of average diameter 41.7 ± 1.1 nm that must correspond 
to the ODN-PNA duplex linked to the PEG-2k layer.  Dynamic light scattering gave a 
hydrodynamic radius of and 30.2 ± 9.1 nm which when subtracted from the original 
diameter of 10.1 nm for the citrate-AuNP gives an increased diameter of 17.1, or an 
increased radius of 8.5 nm.  The increased radius corresponds very well to 6 nm for the 
PNA-ODN helix (18 bp × 0.33 nm/bp) [29] plus 3.8 nm corresponding to the Flory radius 
of PEG-2k [32].  Simple calculations suggest that there is ample surface area to 
accommodate the PNA·ODN duplex and the three PEG2K chains.  A PNA·ODN duplex 
has a diameter of 2.2 nm corresponding to a cross-sectional area of 0.95 nm2 which when 
multiplied by 100 ODNs/AuNP gives and area of 95 nm2 which is 3 times less than the 
calculated surface area of 314 nm2 for a 10 nm diameter gold particle.  If fully extended, 
the PNA·ODN duplex would extend the radius of the gold NP by 6 nm, resulting in an 
outer surface area of 1520 nm2, or 152 nm2 per PNA·ODN duplex.  Given that the Flory 
radius of PEG2K is 3.8 nm and that the center of radius for each PEG2K would be an 
additional 1 nm further out, then the available surface area is calculated to be 3157 nm2.  
Since three PEG2K accommodate a cross-sectional surface area of 114 nm2, the available 
surface would become saturated upon addition of about 28 PNA-PEG3 units. Above this 
amount, one would expect the PEG chains to adopt a more extended, brush-like structure.  
In accord with this analysis, the zeta potential of the particle decreases to -4.1±0.4mV as 
the PEG layer significantly shields the charges [33]. 
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Figure 2.6 Melting curves for Cy5-PNA•ODN-AuNP and Cy5-PNA·ODN. 
Fraction single strand form for Cy5-PNA•ODN-AuNP () from analysis 
of temperature dependent Cy5 fluorescence measurements, and for 
Cy5-PNA·ODN () from analysis of temperature dependent absorbance 
measurements. Data from two heating/cooling cycles were used to generate 
each melting temperature curve. 
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Figure 2.7 Effect of PEGylation on uptake of PNA-Cy5•ODN-AuNP by 
MCF-10A cells.  A) fluorescence imaging of MCF10A cells incubated 
with PNA-Cy5•ODN-AuNP and FAM-dextran (MW 25,000) . B) 
quantification of gold NP uptake by cells by ICP-MS. 
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2.2.4 Cellular Uptake of the PEGylated ODN-Gold NP 
 The interaction of the AuNPs with a normal human breast cell line (MCF10A) 
was examined by confocal microscopy and quantified by ICP-MS.  As expected from 
previous studies with ODN-AuNP [34], Cy5-PNA·ODN-AuNP was internalized by 
MCF-10A cells efficiently in complete growth media without any cell permeation 
enhancing ligand (Figure 2.7A). The particle (red) colocalized with FAM-dextran (green) 
which is considered to enter the cells through an endosomal pathway. Upon complexation 
with PNA-PEG3, the uptake decreased with increasing density of the PNA-PEG3 on the 
gold NP (Figure 2.7B). MCF-10A uptake was reduced by 60% at 60% of PEGylation and 
further reduced by 80% with almost complete PEGylation. The required percentage of 
ODN could possibly be further driven down by utilizing PEG of higher molecular weight 
or higher density per PNA. 
 
2.2.5 Bio-Distribution Studies of the PEGylated Gold NP. 
To determine whether or not the non-covalently assembled 
PNA-PEG3·ODN-AuNP would remain intact in vivo, we carried out biodistribution 
studies with a radiolabeled nanoparticle.  To radiolabel the particle, we synthesized a 
PNA functionalized with DOTA at the carboxy end of PNA via coupling of 
tri-t-butyl-DOTA ester to a carboxy-terminal lysine to give PNA-DOTA (Figure 2.2) 
following deprotection.  PNA-DOTA was first radiolabeled with 64Cu, purified, and then 
hybridized with ODN and ODN-AuNP.  Biodistribution of the labeled species at 1 h, 4 h 
and 24 h post injection (p.i) showed very similar profiles. Both PNA-DOTA•64Cu and 
PNA-DOTA•64Cu·ODN hybrid were cleared very fast from the system through the renal 
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system.  There was some minor accumulation in the liver, lung and gastrointestinal tract 
(stomach and intestine), and negligible uptake in other organs (Figure 2.8). At 1 h p.i., 
the blood retention of PNA-DOTA•64Cu and PNA-DOTA•64Cu·ODN  hybrid were both 
less than 0.5 % ID/g while the kidney uptakes were about 5%. The liver uptakes were 
constant over 24 h, at less than 2% ID/g.  PNA-DOTA•64Cu/PNA-PEG3·ODN-AuNP 
also showed rapid clearance from the systemic circulation (0.31 ± 0.09 %ID/g at 1 h p.i.) 
but much higher retention in liver. The liver uptake was dominant but gradually decreased 
during the 24 h with 32 ± 3% ID/g, 28 ± 7% ID/g, and 21 ± 2% ID/g at 1 h, 4 h and 24 h 
p.i., respectively. The spleen accumulations, however, were stable with about 10% ID/g 
through the study. The sharp contrast between the biodistribution profile of 
PNA-DOTA•64Cu by itself or hybridized to ODN and when it was hybridized to 
PNA-PEG3·ODN-AuNP proves that both the ODN-Au conjugate and PNA/ODN 
hybridization were stable under physiological conditions. The biodistribution  at 24 h 
(21% liver, 11% spleen, 4% kidney) was very similar to that reported in mice at 48 h for a 
20 nm gold nanoparticle coated with thiotic acid-anchored 5K PEG with a hydrodynamic 
radius of 45 nm (30% liver, 15% spleen and 5% kidney)[35].  It is less than optimal, 
however, for potential in vivo delivery application due to its rapid depletion from the 
blood. Further surface passivation will be needed before it can be used for cell specific 
targeting, and is the focus of our further work.  
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Figure 2.8 Biodistribution studies of AuNP and components.   
A) PNA-DOTA-64Cu, B) PNA-DOTA-64Cu•ODN and  
C) PNA-DOTA-64Cu•ODN-AuNP for 1h (a), 4h (b) and 24h (c) p.i. 
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2.3 Conclusions 
In summary, we have developed a DNA hybridization-based self-assembling 
nanoparticle system. We have shown that the oligodeoxynucleotide protected gold 
nanoparticle assembles readily with functionalized complementary peptide nucleic acids 
in a sequence specific manner. We also showed that hybridization yields a stable 
multifunctional nanoparticle under physiological conditions and that non-specific cell 
uptake can be greatly reduced by PEGylation. The resulting non-covalently PEGylated 
gold nanoparticle showed a similar biodistribution pattern in mice to that of a dithiol 
bound PEGylated gold nanoparticle of a similar size.  These results suggest that 
DNA-directed self-assembly could be used for the combinatorial development of and 
optimization of nanoparticle-based imaging and therapeutic agents. 
 
2.4 Experimental 
Materials  All solvents and chemicals were purchased from Sigma-Aldrich and used 
without further purification unless otherwise indicated. Fmoc-Lys(mtt)-OH was 
purchased from EMD Chemicals, Inc. PEG2K-NHS ester was purchased from JenKem 
Technology Co., LTD (M-PEG-SCM, MW2000). Cy5-NHS ester was synthesized by 
Jillian Smith according to a published procedure [36]. The MCF-10A cell lines were 
purchased from ATCC and cultured under the guidelines provided by ATCC. All cell 
culture media were purchased from Invitrogen, Inc. 
 
Size and zeta potential measurements Samples for transmission electron microscopy 
(TEM) measurements were dropped onto PELCO formvar/carbon coated copper grids 
(Ted Pella, Inc.). After 15 min, the excess colloid was removed by filter paper and 2% 
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uranyl acetate was then dropped on the same grid and incubated for another 2 min. Then 
the excess solution was again removed by filter paper. The resulting grids were imaged by 
a FEI Spirit Lab6 TEM. Hydrodynamic diameters and zeta potential were determined by 
Malvern Zetasizer Nano. Surface plasma resonance bands of gold nanoparticles were 
measured by Varian Cary 100.  
 
Synthesis of ODN capped gold nanoparticles ODN-AuNP and ODNnc-AuNP. The ODN 
capped gold nanoparticles were synthesized according to a reported procedure [21]. 
Briefly, sodium citrate was added to boiling chloroauric acid solution to yield gold 
nanoparticles about 11 nm in size [27]. 
TGGTGTGCTTTGTGGATG-O-C3H6-SS-C3H6-OH and 
ACCACACGAAACACCTAC-O-C3H6-SS-C3H6-OH were purchased from IDT and 
reduced with tris(2-carboxyethyl)phosphine at room temperature for one hour to produce 
ODN-SH and ODNnc-SH respectively. The ODNs were then isolated by ethanol 
precipitation and redissolved in water. These freshly prepared thiolated ODN or ODNnc 
solutions were added to the citrate gold nanoparticles (3 nmol per 1 mL of 7 nM 
citrate•AuNP). After 20 min, 10% SDS solution was added to bring the mixture to 0.1% 
SDS. Phosphate buffer (0.1 M, pH 7.4) was added to bring the mixture to 0.01 M 
phosphate and sodium chloride (2.0 M) was added in 30 min intervals to bring the final 
mixture to 0.3 M NaCl. The final mixture was gently shaken for 24 h in the dark under 
room temperature. The ODN-AuNP or ODNnc-AuNP was centrifuged (13500 rcf, 30 
min; 3X) and resuspended in PBS. 
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Determination of the extinction coefficient of citrate•AuNP and ODN-AuNP 10uL of 
citrateAuNP or ODN-AuNP was dissolved in 90uL of freshly made aqua regia under 
room temperature. The mixture was diluted to 5mL with 1% nitric acid. The standard 
solutions was prepared with HAuCl4 standard (Perkin Elmer) at 0.1, 0.5, 1, 5, 10 and 100 
μg/L in 1% nitric acid. The gold concentration was measured on Perkin Elmer Elan DRC 
II ICP-MS using Bi as external reference. The concentration of gold nanoparticles was 
calculated by the following equation.  
!"#$%&'(! "## = !×! = !× 43 !!! !"#$%&'(!!"#$%#&'(&)"# = !"#$!!"#!$#%&'%("#!(!"! )!"#$%&'(! "##! !" ×!!  
 ! is the density of gold, 19.3g/cm3;  r is the radius of the AuNP measured by TEM, 
5.1nm; NA is Avogadro Constant. 
Another 100uL of citrateAuNP or ODN-AuNP was diluted with 0, 100, 300, 700 or 
1500uL 1X PBS the absorbance of each colloid at 520nm for citrateAuNP or 524nm for 
ODN-AuNP was measured and plotted against the corresponding particle concentration 
calculated from the equation. The extinction coefficient was calculated from linear 
regression. (Figure A 2.1) 
 
Determination of the ODN loading of the ODN gold nanoparticles ODN-AuNP and 
ODNnc-AuNP. ODN-AuNP or ODNnc-AuNP (0.5 mL of 10 nM, determined by the 
absorbance at 520nm) was dissolved in 2 mM KCN solution and 1 µL of this solution was 
mixed with 1 µL of  [32P]-ATP, 2 µL of T4 polynucleotide kinase buffer A, 1 µL of T4 
polynucleotide solution and 15 µL of water, incubated at 37 oC for an hour and then 
boiled for 10 min. ODN and ODNnc of known concentrations were also labeled following 
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the same procedure. 32P-labeled ODN or ODNS 50 nM and 1 µL of the radiolabeled 
ODN-AuNP solution were then separately incubated with known amounts of antisense 
PNA in Tris buffer (10 mM, pH 7.5) and NaCl (50 mM), boiled for 5 min and slowly 
cooled down to room temperature. The mixtures was electrophoresed on a 10% native 
PAGE and the radiolabeled bands were imaged on a Biorad Personal Molecular Imager 
and quantified by Biorad Quantity One software. The titration curve between ODN or 
ODNnc and PNA was used to determine the concentration of ODN in the dissolved 
ODN-AuNP solution. The concentration he ODN-AuNP colloid was then determined by 
the absorbance at 520 nm (Figure A 2.2). 
 
General procedure for PNA synthesis All PNAs and conjugates were synthesized on an 
Expedite 8900 PNA synthesizer on 2 µmol of Fmoc-PAL-PEG-PS according to the 
standard automated Fmoc PNA synthesis procedure utilizing commercial PNA and 
peptide monomers (Panagene Inc., Korea). Following the final step of synthesis, the resin 
was washed with dry CH2Cl2 (2 × 3 mL), followed by drying under a stream of N2.  
The resin was then shaken in a vial with trifluoroacetic acid (160 µL) and m-cresol (40 
µL) at room temperature for 1.5 h twice to release and deprotect the PNA. The solution 
from each deprotection was separated from the resin, combined and added to ice-cold Et2
O (1.5 mL). The resulting precipitate was collected by centrifugation and purified by 
reverse-phase HPLC on a Waters XBridge Prep C18 column (130  Å ) with buffer A ( 
0.1% TFA in H2O ) and buffer B ( 0.1% TFA in CH3CN ) on a Beckman System Gold 
instrument equipped with a UV-vis array detector. The flow rate was 2.5 mL/min and the 
gradient was 1% buffer B/min starting from 5% buffer B. The fractions were collected 
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and concentrated to dryness in a SpeedVac (Savant) and characterized by UV-vis and 
MALDI-TOF which was carried out on a PerSpective Voyager mass spectrometer with 
α-cyano-4-hydroxycinnamic acid as the matrix and insulin as the internal reference. 
 
Synthesis of Cy5-PNA.  PNA CAT CCA CAA AGC ACA CCA was synthesized with 
removal of the amino terminal Fmoc group. Cy5-NHS ester (20 µmol) were dissolved in 
anhydrous DMF (100 µL) and mixed with DIPEA (2 µmol). The mixture was incubated 
with the solid support under room temperature for 2 h. Then the solid support was 
separated, washed with DMF. The Cy5-PNA was cleaved and purified by the general 
procedure described above. MALDI: exact [M + H]+ expected 4413.0, found 4415.2 
(Figure A 2.3).  
 
Synthesis of PNA-DOTA and PNA-Cy5. CAT CCA CAA AGC ACA CCA-Lys(Mtt) was 
synthesized with deprotection and capping of the the N terminal amine with 5% acetic 
anhydride and 6% lutidine in DMF. The Mtt protecting group was removed by washing 
the solid support with 1 mL of 1% TFA in DCM several times, 5 min each time, until no 
yellow color was detected. The solid support was then washed with DMF until the eluant 
was no longer acidic, as measured by wet pH paper. For PNA-Cy5 synthesis, Cy5-NHS 
ester (20 µmol) and DIPEA (2 µmol) were dissolved in 100 µL DMF and incubated with 
the solid support at room temperature for 2 h. For PNA-DOTA synthesis, tri-tert-butyl 
1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate (20 µmol), EDC (20 µmol) and 
DIPEA (2 µmol) in 100 µL DMF was incubated with the solid support under room 
temperature overnight. After both syntheses, the reaction mixtures were removed and the 
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solid supports were washed with 1 mL of DMF four times. PNA-DOTA or PNA-Cy5 was 
cleaved and purified by HPLC as described above. MALDI of PNA-DOTA: [M + Na]+ 
expected 5365.3, found 5364.8 (Figure A 2.5). PNA-Cy5 did not give rise to an 
identifiable MALDI peak but PAGE analysis showed hybridization of PNA-Cy5 with 
ODN (Figure A 2.4). 
 
Synthesis of PNA-(PEG2K)3.   
CATCCACAAAGCACACCA-Lys(Mtt)-bAla-bAla-Lys(Mtt)-bAla-bAla-Lys(Mtt) was 
synthesized followed by removal of the amino terminal Fmoc group, the amino terminus 
was acetylated with 5% acetic anhydride and 6% lutidine in DMF. The PNA was cleaved 
from the solid support and purified by HPLC.  PEG2K-NHS ester (10 µmol) was 
dissolved in 100 µL DMF and mixed with 1 µL of DIPEA. 0.0963 µmol of 
Ac-PNA-(Lys-bAla)2Lys was dissolved in 10 µL DMF and added to the PEG solution, 1 
µL at a time. Following each addition, the pH of the reaction of the mixture was checked 
with wet pH paper and additional DIPEA was added to maintain the basicity. The reaction 
mixture was incubated under 55oC for 20 min before the next aliquot was added. After all 
the PNA was added, the reaction mixture was left under room temperature overnight and 
then precipitated with ether. The crude product was separated with HPLC. Each fraction 
was collected, hybridized with 32P labeled ODN and characterized by native PAGE 
(Figure A 2.6).  
 
Fluorescence quenching studies Various amounts of 36.6 µM Cy5-PNA were added to 60 
µL of 5.23 nM ODN-AuNP or ODNnc-AuNP or citrate•AuNP) in 1X PBS. The mixture 
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was incubated under room temperature for 5 min and then the fluorescent was measured 
at 663 nm with excitation at 633 nm. The fluorescence of Cy5-PNA in 1X PBS was 
measured at each concentration as control. 
 
Fluorescence melting temperature studies The Cy5-PNA·ODN-AuNP complex (0.357 
µM Cy5-PNA, 4.7 nM ODN-AuNP in 1X PBS buffer) was heated from 25° to 80 °C at 1 
°C per min and held at 80 °C for 5 min and then cooled down to 25 °C. After 5 min, the 
heating-cooling cycle was repeated. Fluorescence was excited at 633 nm and detected at 
663 nm. The temperature-dependence of fluorescence of Cy5-PNA was measured under 
the same condition in the absence of ODN-AuNP (Figure A 2.7). 
 
Absorbance melting temperature of Cy5-PNA·ODN: The complex from Cy5-PNA (26.4 
µM) and ODN (40 µM) in 1X PBS buffer was heated from 25° to 85 °C at 1 °C per min 
and held at 85 °C for 5 min and then cooled down to 25 °C. After 5 min, the 
heating-cooling cycle was repeated. Absorbance was measured at 260 nm. 
 
Cellular uptake of ODN-AuNP MCF10A cells were seeded in 35 mm glass bottom dish 
and allowed to grow to 70% confluence. PNA50S-Cy5 (1 µL of 1.18 µM) was mixed with 
15 µL 10 nM ODN50-AuNP and incubated at 50 oC for 10 min. After cooling down to 
room temperature, the mixture was mixed with 135 µL of fresh complete media 
containing 0.5ug/mL FAM-dextran (MW 25,000, Invitrogen). Then the cell media was 
removed and replaced with this mixture and incubated at 37 oC with 5% CO2 for 6 h. 
After 5 h, 2 µL of 10 µg/mL Hoechst 3342 was added to the mixture. After 6 h, the 
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mixture was removed and the cells were washed with 1X PBS buffer 5 times and then 
incubated with 2 mL of fresh media. The cellular uptake was visualized by confocal 
microscopy. 
 
Reduction of nonspecific cell binding by PEGylation MCF10A cells were seeded in a 12 
well plate and grown to 90% confluence. PNA-PEG3 was mixed with ODN-AuNP in 
various ratios. The mixtures were incubated at room temperature for 30 min and added to 
the cells with complete cell media. The final concentration of AuNP was 0.9 nM. After 6 
h of incubation at 37oC, cell media was removed and the cells were washed with PBS 
twice. The cells were trypsinized, counted with hemacytometer and centrifuged. Each cell 
pellet was digested with 100 µL nitric acid and hydrogen peroxide mixture (9:1, v/v) 
overnight followed by addition of 200 µL aqua regia. The resulting solution was then 
diluted to 7 mL with 1% nitric acid and analyzed by Perkin Elmer Elan DRC II ICP-MS 
using Bi as external reference.  
 
Radiolabeling. Radiolabeling and experiments were done by Yongjian Liu and Chad 
Jarreau from Department of Radiology, Washington University School of Medicine. 
Copper-64 (t1/2=12.7h, β
+=17%, β−=40%) was produced on the Washington University 
Medical School CS-15 cyclotron by the 64Ni(p,n) 64Cu nuclear reaction at a specific 
activity of 1.85-7.40 GB1/µg at the end of bombardment[37]. PNA-DOTA (320 pmol) 
was incubated with 64Cu (185 MBq) in 100 µL of 0.1 M ammonium acetate buffer (pH 
5.5) at 65 oC for 1 h, with a yield of 52.5 ± 2.4%. The PNA-DOTA64Cu was purified by 
solid-phase extraction after ethylenediaminetetraacetic acid (EDTA, 10 mM in 50 mM pH 
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7.4 phosphate buffer) and the specific activity was 301 ± 14 MBq/nmol [38]. The 
PNA-DOTA used for annealing with ODN and ODN-AuNP was radiolabeled and 
purified following the same procedure with the specific activity of 285 ± 11 MBq/nmol. 
Then 37 MBq of PNA-DOTA64Cu was mixed with ODN. Another 37 MBq (9.1 nmol) of 
PNA-DOTA64Cu was mixed with ODN-AuNP (0.52 nmol) followed by addition of 
PNA-(PEG2K)3 (27.3 nmol). The mixture was purified with Zebu size exclusion column 
(GE Healthcare). 
 
Bio-Distribution. Bio-distribution study was done by Yongjian Liu and Chad Jarreau from 
Department of Radiology, Washington University School of Medicine. All animal studies 
were performed in compliance with guidelines set forth by the NIH Office of Laboratory 
Animal Welfare and approved by the Washington University Animal Studies Committee. 
Biodistribution studies were performed in male C57BL/6 mice weighing 20-25 g 
(n=4/group) and about 370 kBq of PNA-DOTA 64Cu, PNA-DOTA64 Cu·ODN and 
PNA-DOTA64Cu, PEG-ODN50-AuNP in 100 µL saline (APP Pharmaceuticals) was 
injected via the tail vein. The mice were anesthetized with inhaled isoflurane and were 
re-anesthetized before being euthanized by cervical dislocation at each time point (1 h, 4 
h, and 24 h) post injection (p.i.). Organs of interest were collected, weighed and counted 
in a well gamma counter (Beckman 8000). Standards were prepared and measured along 
with the samples to calculate the percentage of the injected dose per gram of tissue 
(%ID/gram) [39]. 
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2.5 Appendix 
 
 
Figure A 2.1 Determination of extinction coefficient of citrateAuNP () 
and ODN-AuNP (×) 
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Figure A 2.2 Determination of the average ODN loading of the ODN·AuNP.  A) 
Titration of ODN of known concentration and ODN from ODN·AuNP with PNA-DOTA 
analyzed by gel electrophoresis. B) Calibration curve generated from Lane 1-6 of A) 
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Figure A 2.3 Preparative HPLC and MALDI-TOF mass spectrum of Cy5-PNA 
53 
 
 
Figure A 2.4 Preparative HPLC trace and gel binding assay of PNA-Cy5. 
The first lane on the left is ODN alone. Upper bands are ODNPNA-Cy5 
hybrid. Lower bands are free ODN. Only the fraction eluted at 39mins 
hybridized with the ODN and thus was used to label ODN-AuNP. 
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Figure A 2.5 Preparative HPLC and MALDI-TOF mass spectrum of PNA-DOTA 
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Figure A 2.6 Preparative HPLC trace and gel binding assay of 
PNA-PEG3. Lane 1: ODN; Lane 2: PNA-PEG; Lane 3-5: fraction 1-3. 
Fraction 1-3 all hybridized with ODN. Fraction1ODN hybrid showed the 
same mobility as PNA-PEGODN hybrid; Fraction2ODN was a mixture 
of PNA-PEG and a species with higher molecular weight. Fraction3ODN 
showed the lowest mobility, indicating that three PEG chains have been 
attached on the PNA 
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Figure A 2.7 A) Original melting curves for Cy5-PNA·ODN-AuNP B) 
Temperature-dependent fluorescence intensity of Cy5-PNA. 
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Chapter 3 
Cationic Peptide Functionalized Gold Nanoparticles 
3.1 Introduction 
Gene transfection is the process of introducing foreign DNA into cells and has 
emerged as a powerful technique for studying gene functions, treating and controlling 
diseases, and cell engineering among other applications [1]. A virus is nature’s solution 
for high gene transfection efficiency and viral methods have been successfully utilized in 
many applications. However, viral methods have an intrinsic problem of immunogenicity 
and induction of mutation responses [2]. Non-viral methods that utilize physical or 
chemical methods have attracted more and more interest as gene transfection agents [3, 
4]. Physical methods like particle bombardment, electroporation, and fine-needle 
injection utilize physical forces to deliver a gene into a cell. Chemical methods use 
cationic carriers such as cationic peptides, cationic lipids, and cationic synthetic polymers 
to form complexes with DNA and penetrate cellular membranes. However, many of the 
existing cationic non-viral transfection agents also show high cytotoxicity. Development 
of new non-viral methods to facilitate high DNA binding and transfection efficiency with 
low cytotoxicity is strongly desirable. 
In the past two decades, a number of approaches to gene transfection have been 
developed based on gold and other inorganic nanoparticles [5-12]. Most of the cationic 
gold nanoparticles rely on thiolated primary or tertiary amines as capping agents to 
provide charges. Sandhu et al. reported gene transfection using gold nanoparticles 
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modified with N,N,N-trimethyl(11-mercaptoundecyl) ammonium chloride and alkylthiol 
with several chain lengths [10]. Niidome et al. reported a gold nanoparticle based 
transfection agent with 2-aminoethanthiol as a capping agent. These nanoparticles suffer 
from poor DNA binding affinity due to the inherent low charge density and the low 
binding affinity between amino group and phosphate group.  The guanidinium group is a 
much better binder for ODNs and various oligoarginine derivatives have been developed 
for gene transfection due to their high ODN binding affinity and cell permeation ability 
[13]. In this chapter, a series of oligoarginine peptide modified gold nanoparticles were 
prepared and characterized. The effect of the length of the oligoarginine chain and the 
function of other amino acids in the sequence were investigated.  
3.2 Results and Discussion 
3.2.1 Arginine-rich Peptide Modified Gold Nanoparticle Synthesis 
Chloroauric acid (HAuCl4) was reduced by sodium borohydrate (NaBH4) in the 
presence of arginine-rich peptides. The resulting nanoparticles are similar in size and 
surface plasmon band. Figure 3.1 is the TEM image of all the cationic gold nanoparticles 
(cAuNP) synthesized. Table 3.1 is the summary of the diameters and surface plasmon 
resonance band of all the cAuNP studied. AuNP-CTTR5 measured 11.6 ± 1.8 nm; AuNP-
CTTR9 measured 17.0 ± 2.6 nm; AuNP-CTTR13 measured 13.5 ± 2.4 nm; AuNP-
CVVR9 measured 12.1 ± 1.9 nm; AuNP-CR13 measured 11.8 ± 3.1 nm; AuNP-CTTR17 
measured 10.9 ± 2.1 nm. The cAuNPs are smaller compared to gold nanoparticles 
synthesized by similar methods [14, 15], presumably due to more surface charges 
provided by the arginines in the sequences. The zeta potential of AuNP-CTTR9 was 29.4 
± 2.4 mV; AuNP-CVVR9 was 41.2 ± 4.9 mV; AuNP-CR13 was 26.8 ± 2.9 mV. 
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Figure 3.1 TEM images of cAuNP studied in this chapter. A) AuNP-
CTTR5; B) AuNP-CTTR9; C) AuNP-CTTR13; D) AuNP-CR13; E) 
AuNP-CVVR9; F) AuNP-CTTR17. 
 
E) 
F) 
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Figure 3.2 Absorption of the cAuNPs. ( ) AuNP-CTTR5; (✕) AuNP-
CTTR9; () AuNP-CTTR13; (+) AuNP-CR13; () AuNP-CVVR9; () 
AuNP-CTTR17. All the absorption curves are normalized to 1 at SPB. 
 
                   Table 3.1 Diameter and surface plasmon band of each cAuNP. 
 
 
 
Sample Diameter (nm) SPB (nm) 
AuNP-CTTR5 11.6 ± 1.8 528 
AuNP-CTTR9 17.0 ± 2.6 532 
AuNP-CTTR13 13.5 ± 2.4 529 
AuNP-CR13 11.8 ± 3.1 523 
AuNP-CVVR9 12.1 ± 1.9 528 
AuNP-CTTR17 10.9 ± 2.1 528 
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3.2.2 Stability of the cAuNPs in Different Ionic Strengths 
High ionic strength is known to induce aggregation of electrostatically stabilized 
colloids as counter ions form ion pairs with the surface ions and thus neutralize the 
charges. For transfection purposes, the colloid needs to be stable at or above the inter- 
and intra-cellular salt concentration, which could be over 0.2M [16]. Therefore, the 
stability against increasing salt concentration is an important measurement of colloid 
stability. We used dynamic light scattering (DLS) to measure the increase in diameter of 
the cAuNPs as an indication of aggregation. Figure 3.3 shows that all the cAuNPs 
stayed well dispersed at 0.5 M of NaCl. At 0.6 M NaCl, AuNP-CTTR5 started to 
aggregate. The stability of cAuNPs increased as the number of arginine per sequence 
increased. AuNP-CR13 showed the best stability and it remained non-aggregated at 1 M 
NaCl. When threonine was replaced with valine, the stability appeared to be lower. 
When threonine was removed from CTTR13, the stability increased. This result is not 
very consistent with previous reported studies [17], maybe due to the influence of 
arginines at the C terminus of the peptides. 
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Figure 3.3 Diameters of cAuNPs in different salt concentrations. () 
AuNP-CTTR5; (✕) AuNP-CTTR9; () AuNP-CVVR9; () AuNP-
CTTR13; () AuNP-CR13. 
 
3.2.3 Stability of the cAuNPs as a Function of pH 
To evaluate the suitability of the cAuNPs as potential in vitro transfection agents, 
we measured the stability of the cAuNPs under different pHs in 10 mM phosphate buffer 
with DLS. As shown in Figure 3.4, all of the cAuNPs remained dispersed below pH 5. 
However, as the basicity increased to pH 6, all the cAuNPs except for AuNP-CR13 
started to aggregate. At physiological pH, all the cAuNPs showed various degrees of 
aggregation and the colloid visibly turned purple. In general, the stability increases as 
number of arginines per sequence increases. The observed aggregation at pH 7 was 
unexpected since the arginine is the most basic amino acid among all natural amino 
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acids. The pKa of the guanidinium group of the side chain of arginine is 12.8, so nearly 
100% of the guanidinium groups should be protonated at pH 7. To further probe the 
influence of pH, 10mM HEPES (2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic 
acid) buffer (pH 7.0 and 7.5) and 10mM borate buffer (pH 8.0 and 8.5) were also tested 
(Table 3.2). Unlike phosphate buffer, HEPES buffer did not induce aggregation at pH 7 
and pH 7.5. The colloid remained well dispersed even at pH 8 and pH 8.5 in borate 
buffer.  This observation indicates that the pH-induced aggregation is largely due to the 
strong affinity between guanidinium group and phosphate group (Figure 3.5). As the pH 
increases, more phosphate ions are deprotonated and form hydrogen bonds with the 
guanidinium groups and hence cause inter-particle bridging. HEPES and borate, on the 
other hand, do not form strong hydrogen bonds with arginines. 
 
Figure 3.4 Diameters of cAuNPs in 10 mM phosphate buffer of different 
pHs. () AuNP-CTTR5; (✕) AuNP-CTTR9; () AuNP-CVVR9; () 
AuNP-CTTR13; () AuNP-CR13. 
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Figure 3.5 Proposed interaction between guanidinium groups and 
phosphate groups. 
 
Table 3.2 Summary of the hydrodynamic diameters of AuNP-CR13 in different 
buffers and pH. 
Buffer(10mM), Phosphate, HEPES, Borate,
pH, 7.0, 7.5, 7.0, 7.5, 8.0, 8.5,
d,(nm), 707.9, 676.9, 16.5, 15.7, 17.3, 16.7,
STDEV, 206.3, 209.4, 4.4, 4.2, 5.2, 5.0,
 
  
!"
!"
! 72!
 
3.2.4 Reversibility of the Phosphate-Induced Aggregation 
To better understand the nature of the phosphate-induced aggregation, acid was 
added to the aggregated colloid. When the pH dropped below 5, the colloid immediately 
returned to the original red color, indicating that the particles were dispersed again. 
TEM was performed on the colloid at pH 7.5 and pH 3 (Figure 3.6). The images clearly 
showed that the aggregation was completely reversible. This enabled the colloid to be 
purified conveniently by inducing aggregation at higher pH. When the supernatant was 
removed and the aggregate was washed, the colloid could then be re-dispersed with the 
addition of acid.  
 
Figure 3.6 TEM images of AuNP-CTTR9 before and after acid addition 
A) at pH7.5; B) acidified to pH 3 by addition of HCl. 
 
3.2.5 ODN Binding Ability of the cAuNPs 
ODN binding ability of the cAuNPs was evaluated by a gel retardation essay. 
cAuNPs were mixed with 32P labeled ODN in different weight ratios and separated by 
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native PAGE (Figure 3.7). Peptide CTTR13 was also tested as a control to determine the 
retardation effect of cationic peptide alone. All the cAuNPs showed different gel shift 
patterns than the peptide alone, indicating that the retardation effect was because of 
assembly of the peptides on the cAuNP. Except for the case of AuNP-CTTR17, the ODN 
binding ability increased as the arginine content of the capping peptide increased. Among 
all the cAuNP tested, AuNP-CR13 showed the highest ODN binding affinity, which 
bound the majority of the ODN at 1:1 w/w ratio. The presence of threonine or valine in 
the sequences did not seem to affect the binding ability. 
 
Figure 3.7 Gel retardation assay of cAuNP/ODN complexes at different 
AuNP/ODN weight ratios. Radioactive  5’-32P-labeled 
d(TGTGACACACAGCGCTACAA) (25 nM) was incubated with 
cAuNPs  in 10 mM Tris buffer (pH 7.5) and 50 mM NaCl for 30 min and 
then loaded to 10% native polyacrylamide gel. The band at the top of the 
gel is the ODN bound to the cAuNP, and the band at the bottom is free 
ODN.  
3.2.6 cAuNP Cytotoxicity 
To evaluate the cytotoxicity of the two best ODN binding cAuNPs, AuNP-
CVVR9 and AuNP-CR13 on pLuc705 HeLa cells, the MTT assay was employed (Figure 
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3.8). This assay is performed by adding a premixed, optimized Dye Solution to cell 
culture in a 96-well plate. During a 4-hour incubation, living cells convert the MTT 
tetrazolium component of the Dye Solution into a formazan product. The 
Solubilization/Stop Solution is then added to the culture wells to solubilize the formazan 
product, and the absorbance at 570 nm is recorded using a 96-well plate reader. For 
comparison, peptides CVVR9 and CR13 were also evaluated simultaneously (Figure 
3.9). The cytotoxicity of arginine-rich cell permeating peptides is well documented [18, 
19], which also agrees with our observation. The cytotoxicity increased dramatically for 
CR13 as the concentration increased, while CVVR9 showed much less but significant 
toxicity. Interestingly, AuNP-CVVR9 and AuNP-CR13 did not show any toxicity at all 
even at a very high concentration. We estimated that the peptide strands were packed on 
the gold surface at a density of about 500 peptides/AuNP. Both AuNP-CVVR9 and 
AuNP-CR13 showed much higher cell viability than the peptide alone at an equivalent 
concentration. This is likely because that the membrane rupture caused by oligoarginine 
on the cAuNP is localized compare to the global damage caused by free peptide and a 
localized rupture may be easier to recover from. This observation indicates that cAuNP 
could potentially provide much higher DNA binding strength and cell penetrating ability 
with much lower toxicity.  
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Figure 3.8 Relative cell viability of pLuc705 HeLa cells in the presence of 
various concentrations of AuNP-CVVR9 and AuNP-CR13. “Cell” is the 
negative control with no additives. 
 
Figure 3.9 Relative cell viability of pLuc705 HeLa cells in the presence of 
various concentrations of () CVVR9 and () CR13.  
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3.2.7 Preparation of Peptide Gold NP by a Ligand Exchange Method 
3.2.7.1 Synthetic Approach 
Instead of forming the peptide nanoparticles by incubating the gold salt with the 
peptide during reduction with NaBH4, we decided to see if ligand-peptide exchange of 
gold nanoparticles fabricated by other methods would also be feasible. Gold 
nanoparticles made from citrate reduction (Figure 3.10A) and CTAB seeding-growth 
method (Figure 3.10C) were tested as templates for peptide assembly. After ligand-
peptide exchange, both colloids retained the low polydispersity of the original 
nanoparticle. The CTABAuNP appeared to be a better candidate for cAuNP synthesis 
than citrateAuNP because a much larger amount of the peptide is required to be added to 
negatively charged citrateAuNP to prevent aggregation. In comparison, the positively 
charged surfactant CTAB is a stronger stabilizer and more compatible with positively 
charged peptides. The displaced CTAB in the colloid could be removed by 
centrifugation.  We find this approach to be much more convenient and versatile than the 
direct reduction method. The size of the colloid is more controllable and tunable in the 
seed-growth process and a combinatorial library of peptide-AuNP could be prepared 
quickly. 
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Figure 3.10 TEM images of citrate gold nanoparticles A) before and B) 
after CR13 exchange. CTAB gold nanoparticles C) before and D) after 
CR13 exchange. 
 
3.2.7.2 Choice of Peptide  
To further tune the surface properties of the cAuNP, a lysine rich peptide, 
K10Y2C was synthesized. Three colloids were prepared by exchanging with R13C only, 
R13C-AuNP (Figure 3.11A), K10Y2C only, K10Y2C-AuNP (Figure 3.11C), and equal 
amount of K10Y2C and R13C together, R13C/K10Y2C-AuNP (Figure 3.11B), with 
A) B) 
C) D) 
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CTABAuNP following the same procedure. All three nanoparticle colloids retained the 
polydispersity of the original CTABAuNP. 
 
Figure 3.11 TEM images of A) R13C-AuNP; B) R13C/K10Y2C-AuNP; 
C) K10Y2C-AuNP made from CTABAuNP. 
3.2.7.3 Properties of the New cAuNP 
A series of experiments were conducted to evaluate the properties of R13C-
AuNP, K10Y2C-AuNP and R13C/K10Y2C-AuNP synthesized with the new approach. 
Figure 3.12 shows that R13C-AuNP (CTAB) behaves in the same way as R13C-AuNP 
(direct reduction) in phosphate buffers. However, K10Y2C-AuNP did not aggregate at all 
even in pH 8 phosphate buffer, which further supports the idea that the aggregation of 
arginine-rich gold nanoparticle in phosphate buffer was due to the affinity between 
phosphate groups and guanidinium groups. The hybrid R13C/K10Y2C-AuNP exhibited 
intermediate stability, starting to aggregate moderately at pH7. 
R13C-AuNP from the CTAB method showed similarly strong ODN binding 
ability shown by R13C-AuNP from the direct reduction method (Figure 3.13). When all 
the arginine was replaced with lysine, the binding ability decreased dramatically. Again, 
the hybrid R13C/K10Y2C-AuNP showed intermediate affinity, though not as high as 
what would be expected for 50% R13C loading, which indicates that the actual peptide 
A) B) C) 
! 79!
composition on the gold surface might not be the same as that used in the synthesis and 
K10Y2C might be more preferable. 
To rapidly and quantitatively evaluate the cell transfection efficiencies of all three 
AuNPs, we adopted the luciferase splice correction assay developed by Kole and 
coworkers. This assay relies on a luciferase gene (pLuc705) that results in a longer, mis-
spliced mRNA that encodes a defective luciferase. In the presence of a phosphorothioate 
2′-O-methyl- oligodeoxyribonucleotide (ps-MeON) CCUCUUACCUCAGUUACA, 
complementary to the aberrant splice site, correct splicing is restored in a dose-dependent 
and sequence-specific manner, resulting in an active luciferase [20]. We employed MTT 
assay for cytotoxicity assessment. Their cytotoxicities were also assessed by the MTT 
assay (Figure 3.14). Although all the particles were non-toxic to the cells even at a very 
high concentration, none of them appeared to be able to transfect the cells effectively at 
an AuNP/ODN w/w ratio of 10 or 20. Further investigation is needed to understand and 
optimize the transfection process. 
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Figure 3.12 Hydrodynamic diameter of () R13C-AuNP, () 
R13C/K10Y2C-AuNP, and () K10Y2C-AuNP in phosphate buffer 
of different pH. 
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Figure 3.13 A) Gel retardation essay of cAuNP/ODN complexes at 
different AuNP/ODN weight ratios. Radioactively  5’-32P-labeled 
d(TGTGACACACAGCGCTACAA) (25 nM) was incubated with 
cAuNPs  in 10 mM Tris buffer (pH 7.5) and 50 mM NaCl for 30 min and 
then loaded to 10% native polyacrylamide gel. The band at the top is the 
ODN bound to the cAuNP, and the band at the bottom is free ODN. B) 
Quantification of the ODN binding, analyzed by BioRad Quantity One. () 
R13C-AuNP, () R13C/K10Y2C-AuNP and () K10Y2C-AuNP. 
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Figure 3.14 A) Luciferase splice correction activity and B) cytotoxicity of 
cAuNP-ps-MeON at different Au/ODN w/w ratios, compared to the 
commercially available transfection agents Lipofectamine, after 24 h 
incubation with 0.2 µM ps-MeON.  
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3.3 Conclusions 
In summary, we have synthesized a library of arginine-rich peptide functionalized 
gold nanoparticles through direct sodium borohydride reduction. We have shown that 
these gold nanoparticles are stable in high salt concentration and physiological pH in 
non-phosphate containing buffers. The strong affinity between the arginine and the 
phosphate group resulted in reversible aggregation under high pH phosphate buffers as 
well as high ODN binding affinity. Unlike the free oligoarginine peptide, the gold 
nanoparticles showed no cytotoxicity in pLuc705 HeLa cells even at a high 
concentration. An improved post-synthetic ligand exchange strategy proved to be more 
convenient and tunable than the direct reduction method. A library of three cationic gold 
nanoparticles was synthesized using the new strategy with different surface peptide 
combinations. The new cAuNP showed improved stability, decreased ODN binding 
affinity, and comparable transfection capability and cytotoxicity compare to the arginine-
rich AuNP. With further optimization of the surface properties by the combinatorial 
strategy described, this cationic peptide gold nanoparticle system may eventually find use 
as a stable, safe and effective transfection agent. Morever, this combinatorial strategy can 
be a powerful tool to prepare a large library of gold nanoparticles quickly and 
conveniently for other applications. 
3.4 Experimental 
Materials All solvents and chemicals were purchased from Sigma-Aldrich and used 
without purification, unless otherwise indicated. Fmoc amino acids were purchased from 
AAPTEC. Fmoc-PAL-PEG-PS resin was purchased from Applied Biosystems. A 
luciferase splice-correcting phosphorothioate 2’-O-methyl-oligoribonucleotide (ps-
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MeON, CCUCCUACCUCAGUUACA) and the oligodeoxynucleotide 
d(TGTGACACACAGCGCTACAA) used in gel retardation assay were purchased from 
Integrated DNA Technologies, Inc and used directly without further purification. The 
pLuc705 HeLa cell line was a generous gift from Dr. R. Kole (University of North 
Carolina, Chapel Hill, NC). Lipofectamine2000 was obtained from Invitrogen 
Laboratories, Inc. Steady-Glo® Luciferase Assay reagent and CellTiter 96® Non-
Radioactive Cell Proliferation Assay (MTT) kit were purchased from Promega Co. All 
cell culture media was purchased from Invitrogen, Inc. 
 
Measurements UV-Vis spectra were recorded on a Varian 100 UV-Vis spectrometer. 
Samples for transmission electron microscopy (TEM) measurements were prepared on 
Formvar/carbon coated copper grids. Micrographs were collected at 15,000 × 
magnifications on a FEI Spirit Lab6 TEM. Dynamic light scattering (DLS) was measured 
on Malvern Nano Sizer. Measurements were made at 25 ± 1 °C. Scattered light was 
collected at a fixed angle of 173°.  
 
Synthesis of CTTR5, CTTR9, CTTR13, CTTR17, CVVR9, CR13 Arginine-rich cationic 
peptide were synthesized using standard solid phase automated Fmoc chemistry on a 6 
µmol scale. After the synthesis, the Fmoc group on the amino terminus was removed by 
mixing 30 mg of resin with 1 mL 20% piperidine in DMF for 30 min. The resin was then 
washed with 1 mL DMF four times and 1 mL of DCM once, then dried under nitrogen. A 
cleavage cocktail (440 µL of trifluoroacetic acid, 25 µL of water, 25 µL of phenol and 10 
µL of triisopropylsilane was added into the resin and the mixture was incubated under 
! 85!
room temperature for 3 h. After the cleavage cocktail was separated from the resin, 1.2 
mL of cold anhydrous diethyl either was added to the cleavage cocktail to precipitate the 
crude peptide. The resulting precipitate was collected by centrifugation and purified by 
reverse-phase HPLC on a Waters XBridge Prep C18 column (130  Å ) with buffer A ( 
0.1% TFA in H2O ) and buffer B ( 0.1% TFA in CH3CN ) on a Beckman System Gold 
instrument equipped with a UV-vis array detector. The flow rate was 2.5 mL/min and the 
gradient was 1%/min starting from 5% buffer B. The fractions were collected and 
concentrated to dryness in a Savant SpeedVac  and characterized by UV-vis and MALDI-
TOF which was carried out on a PerSpective Voyager mass spectrometer with α-cyano-4-
hydroxycinnamic acid as the matrix and insulin as the internal reference. MALDI: 
CTTR5 exact (M+H)+ expected: 1103.6 found: 1103.5 (Figure A 3.1); CTTR9 exact 
(M+H)+ expected: 1728.0 found: 1734.0 (Figure A 3.2); CTTR13 exact (M+H)+ 
expected: 2351.4 found: 2352.2 (Figure A 3.3); CTTR17 exact (M+H)+ expected: 
2976.8 found: 2977.1; CR13 exact (M+H)+ expected: 2150.3 found: 2150.0 (Figure A 
3.4) CVVR9 exact (M+H)+ expected: 1723.9 found: 1724.0 (Figure A 3.5) 
 
Synthesis of AuNP-CTTR5, AuNP-CTTR9, AuNP-CTTR13, AuNP-CTTR17, AuNP-
CVVR9, and AuNP-CR13 1mM HAuCl4 solution (1 mL) was mixed with 5 eq of the 
corresponding peptide solution at room temperature for 15 min, followed by addition of 1 
µL of 10 mM NaBH4 solution under vigorous stirring. The reaction mixture was left 
stirring under room temperature for 4 h in the dark. The resulting gold colloid was stored 
at 4 oC in the dark. 
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Determination of colloid stability under different salt concentration Serial amounts of 2 
M NaCl solution was added to 100 µL of 2 nM cAuNP colloid to achieve 0, 0.1, 0.2, 0.3, 
0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1 M of final NaCl concentration. The mixtures were then 
incubated at room temperature for 30 min and the hydrodynamic diameters of the 
resulting gold nanoparticles were measured by dynamic light scattering. 
 
Determination of colloid stability under different buffer condition Phosphate buffer (10 
µL of 1 M pH 5, 6, 6.5, 7, 7.5, 8) or 1 M HEPES buffer (pH 7, 7.5) or 20 µL of 0.5 M 
borate buffer (pH 8, 8.5) was added to 100 µL of 2 nM cAuNP colloid. The mixture was 
then incubated at room temperature for 30 min and the hydrodynamic diameters of the 
resulting gold nanoparticles were measured by dynamic light scattering. 
 
Gel retardation assay The oligodeoxynucleotide d(TGTGACACACAGCGCTACAA) 
was 5’-labeled by [32p-ϒ]-ATP with T4 polynucleotide kinase. Serial amounts of cAuNPs 
were mixed with 50 nM radiolabeled ODN at the w/w ratio indicated in Figure 3.6 in 10 
mM Tris pH 7.5 buffer with 50 mM NaCl for 30 min. The  mixture (20 µL) was then 
mixed with 5 µL of 50% glycerol and 5µL of the final mixture was loaded onto a10% 
native polyamide gel. 
 
Cytotoxicity Cytotoxicity of cAuNPs was evaluated on pLuc705 HeLa cells (human 
cervical cancer cell line). Cells were maintained in DMEM containing 10% FBS, 
streptomycin (100 µg/mL), and penicillin (100 units/mL) with additional G418 (100 
µg/mL) and hygromycin B (100 µg/mL) at 37 oC in a humidified atmosphere with 5% 
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CO2. The cells were seeded in a 96-well microtitier plate at a density of 2×104 cells/well 
and cultured for 24 h in 100 µL complete growth media. At the time of the cytotoxicity 
experiment, the media was replaced with 100 µL of DMEM containing various 
concentrations of AuNP-CVVR9 or AuNP-CR13, CVVR9, CR13, or no additive 
(negative control) as indicated in Figure 3.7. After 24 h incubation at 37oC, 15 µL 
CellTiter 96® Non-Radioactive Cell Proliferation Assay (MTT) dye solution was added. 
The contents were mixed and the plate was allowed to incubate at 37 oC temperature for 4 
h followed by addition of 100 µL of the stabilizing solution and 1 h additional incubation 
at 37 oC. Absorbance at 600 nm was recorded on a SpectraMax Plus 380 (Molecular 
Devices). The relative cell viability was calculated by the following equation: 
Cell viability (%) = (Abs(sample)/Abs(negative control))×100 
Where Abs(negative control) was obtained in the absence of particles or peptides and Abs(sample) 
was obtained in the presence of cAuNP or peptide. 
 
Synthesis of citrate gold nanoparticles and CTAB gold nanoparticles. The citrate gold 
nanoparticles were synthesized according to a reported procedure [21]. Briefly, sodium 
citrate was added to boiling chloroauric acid solution to yield gold nanoparticles about 11 
nm in size. The CTAB gold was also synthesized following a published procedure [22]. 
Briefly, a 3.5 nm seed was prepared by adding sodium borohydride into a mixture of 
chloroauric acid and sodium citrate at room temperature. Growth stock solution was 
made by mixing chloroauric acid and cetyltrimethylammonium bromide (CTAB). 
Ascorbic solution was added to the growth solution followed by the seed solution. The 
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colloid turned red immediately and was stirred for another 10 min. The excess CTAB 
was removed by centrifugation.  
 
Determination of the extinction coefficient of CTABAuNP 10 µL of CTABAuNP 
colloid was dissolved in 90 µL of concentrated nitric acid and then diluted 100, 1000 and 
10000 times with 1% nitric acid. The standard solutions was prepared with HAuCl4 
standard (Perkin Elmer) at 0.1, 0.5, 1, 5, 10, 100 µg/L in 1% nitric acid. The gold 
concentration was measured on Perkin Elmer Elan DRC II ICP-MS using Bi as external 
reference. Another series of CTABAuNP colloid was diluted by 2, 2.5, 3.3, 5, and 10 
times in double distilled water. The absorbance of the diluted colloid at 517 nm was 
measured and plotted against corresponding concentration. The extinction coefficient was 
calculated from linear regression (Figure A 3.6). 
 
Synthesis of R13C-AuNP, K10Y2C-AuNP and R13C/K10Y2C-AuNP 0.66 uL of R13C 
(202 mM) or 3 µL of K10Y2C (44 mM) or a mixture of 0.33 µL of R13C and 1.5 µL of  
K10Y2C was first mixed with 5 µL of 50 mM TCEP followed by addition of 1 mL of 
29.3 nM CTABAuNP and then incubated at room temperature. NaCl (50 µL of a 2M 
solution) was added to the mixture every 20 min until the final concentration of NaCl 
reached 0.3 M. The mixture was then allowed to incubate under room temperature in the 
dark overnight. To remove the unreacted peptide, the colloid was centrifuged at 126,000 
rcf for 30 min. The supernatant was removed. The pellet was re-dispersed in double 
distilled water.  This process was repeated twice. The final concentration was determined 
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by absorbance at 520 nm (λmax) using the extinction coefficient of CTAB-AuNP. 
ε517=0.0746 nM-1cm-1. 
 
Cell culture cAuNP mediated transfection and cytotoxicity was evaluated on pLuc705 
Hela cells by luciferase expression. Cells were maintained in DMEM supplemented with 
10% FBS, G418 (100 µg/mL) hygromycin B (100 µg/mL) streptomycin (100 µg/mL), 
and penicillin (100 units/mL) at 37 °C in a humidified atmosphere with 5% CO2. 
 
Luciferase antisense splicing correction assay pLuc705 HeLa cells were seeded in a 96-
well microtiter plate at a density of 2 × 104 cells/well and cultured for 24 h in 100 µL 
complete media. ps-MeON (phosphorothioate 2′- O-methyl-oligoribonucleotide: 
CCUCUUACCUCAGUUACA) was complexed with cAuNPs at predetermined 
AuNP/ODN w/w ratios and incubated for 30 min before use. At the time of the 
transfection experiment, the medium was replaced with 80 µL of DMEM, to which the 
cSCK/ps-MeON complexes were added. Following 24 h incubation periods, 100 µL 
Steady-Glo® Luciferase assay reagent was added. The contents were allowed to incubate 
at room temperature for 10 min to stabilize the luminescence signal. Luminescence 
intensities were recorded on a Luminoskan Ascent® luminometer (Thermo Scientific) 
with an integration time of 1 second per well. 
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3.5 Appendix 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A 3.1 Preparative HPLC trace and MALDI-TOF mass spectrum of 
CTTR5. 
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Figure A 3.2 Preparative HPLC trace and MALDI-TOF mass spectrum of 
CTTR9. 
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Figure A 3.3 Preparative HPLC trace and MALDI-TOF mass spectrum of 
CTTR13. 
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Figure A 3.4 Preparative HPLC trace of CR13. 
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Figure A 3.5 Preparative HPLC trace and MALDI-TOF mass spectrum of 
CVVR9 
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Figure A 3.6 Calculation of the extinction coefficient of CTABAuNP. 
The calibration equation and R squared value are shown on the chart. ε517 
= 0.0746 nM-1cm-1. 
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Optimizing the synthetic conditions for AuNP-CTTR5, AuNP-CTTR9, AuNP-CTTR13, 
AuNP-CTTR17, AuNP-CVVR9, and AuNP-CR13: The optimization of the reaction 
conditions was done in a clear 96 well plate. The color of the resulting colloid and TEM 
images were used to detemine the outcome of each reaction. A bright red colloid and 
narrow size distribution from TEM were considered as successful outcomes. Each 
reaction was done in 50 µL scale and the mixing was done on a shaker at room 
temperature. The following parameters were investigated: 
1. Concentration of HAuCl4: 50 µL of 1 mM HAuCl4 solution (A) or 0.6 mM HAuCl4 
solution (B) were mixed with 3.75 µL of CTTR5 solution (20 mM), incubated at room 
temperature for 15 min followed by addition of 0.5 mM NaBH4 solution (1 µL or 0.6 µL 
respectively). Within 20 min, colloid A developed red color while colloid B developed 
purple color (Figure A 3.7). 
 
  
 
 
 
 
 
 
Figure A 3.7 TEM images of AuNP-CTTR5 synthesized from different HAuCl4 
concentration. A) 1 mM B) 0.6 mM 
 
A) B) 
! 97!
2. Peptide to HAuCl4 molar ratio: 50 µL of 1 mM HAuCl4 solution was mixed with A) 
1.6 µL (1.5 eq), B) 3.2 µL (3 eq), C) 4.3 µL (4 eq), D) 5.3 µL (5eq) and E) 7.5 µL (7eq) 
of 46.8 mM CTTR5 solution, incubated at room termperature for 15 min, followed by 
addition of 1 µL of 0.5 mM NaBH4 solution. Within 20 min, Colloid A and B developed 
purple color while Colloid C, D and E developed red color. (Figure A 3.8) 
                         
            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A 3.8 TEM images of AuNP-CTTR5 synthesized from different equivalence of 
CTTR5 solution.  A) 5 eq B) 6 eq C) 7 eq 
A) B) 
C) 
! 98!
3.  Reducing agent: two reducing agents were tested in the synthesis: sodium borohydride 
and tryptophan. When HAuCl4 solution (0.2 mM, 6.5 mL) was mixed with tryptophan 
(14 mM, 0.35 mL) and shaked at room temperature, 28 nm monodispersed gold 
nanoparticles formed within 20 min (Figure A 3.9A). However, when the peptide was 
added, no nanoparaticles with defined sized was formed (Figure A 3.9B). When sodium 
borohydride was used as reducing agent, 0.5%, 1% or 2% equivalent of NaBH4 was 
added (0.5, 1, or 2 µL of 0.5 mM NaBH4 solution into a mixture of 50 µL of 1 mM 
HAuCl4 and 5.4 µL of 46.8 mM CTTR5 solution), 1% equivalence yielded best dispersed 
colloid while 0.5% equivalence yielded slow reduction and ununiformed particle size and 
2% equivalence resulted in ununiformed particle size (Figure A 3.9 C-E). The optimized 
synthetic conditions of AuNP-CTTR5 were applied to the rest of the cAuNP library. 
 
 !!!!!!!!!
  
A) B) 
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Figure A 3.9 TEM images of AuNP-CTTR5 synthesized with different reducing agent. A) 
tryptophan (without CTTR5) B) tryptophan (with CTTR5) C) 0.5% NaBH4 D) 1% 
NaBH4 E) 2% NaBH4 
 
 
 
C) D) 
E) 
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Chapter 4 
Biodegradable Peptide Nanoshell 
4.1 Introduction 
Nanoshells have gained significant interest in recent years due to their unique 
chemical, physical, and biological properties and their versatility to carry payload. They 
have been used in a wide spectrum of applications in imaging [1, 2], drug delivery [3, 4] 
and catalysis [5]. Many different methods have been employed to prepare these structures 
based on layer-by-layer process [6], cross-linking of micelles [7-9], nanoparticle self-
assembly [10, 11] and templating techniques [12-15]. Among all existing strategies, the 
templating method is especially attractive because it takes advantage of both the 
convenience to synthesize and control the morphology of the template and the readiness 
to assemble the nanoshell material on the template. The resulting nanoshells are usually 
homogeneous and well-defined.  
Gold nanoparticles (AuNPs) are one of the most popular nanoparticle systems for 
surface modification, due to the unique affinity between gold and sulfur. Thiolated 
ligands such as polymers [16], oligodeoxynucleotides (ODNs) [17], peptides [18-20] and 
proteins [21] have been deposited on the gold surface for different functionalities. In 
some studies, the gold nanoparticles were used as templates and were removed after the 
crosslinking of the surface ligands. Zhang and his coworkers developed a polymeric 
nanopod through gold nanoparticle templated and catalyzed crosslinking of polymers 
[22]. They demonstrated that after removal of the AuNP template, the crosslinked 
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nanopod still remained its spherical geometry and by using AuNPs of different diameters, 
they were able to obtain hollow nanopod of similar morphology.  Cross-linking took 
place between the propargyl groups on the surface of the particle (Figure 4.1). Inspired 
by that work, Culter and his coworkers crosslinked ODNs on the AuNP template [23].  
Each ODN had 10 alkyne-modified thymines next to the thiol terminus. The resulting 
polyvalent nucleic acid nanostructures were well-defined in shape, size and ODN 
loading.  The cellular permeation and transfection ability of the nanostructure were also 
comparable to the ODN modified gold nanoparticles. 
 
Figure 4.1 Tentative cross-linking mechanism of propargyl groups on the surface 
of the gold nanoparticle. Adapted with permission from [22] Zhang, K., et al., Nanopod 
Formation through Gold Nanoparticle Templated and Catalyzed Cross-linking of 
Polymers Bearing Pendant Propargyl Ethers. Journal of the American Chemical Society, 
2010. 132(43): p. 15151-15153. Copyright 2010 American Chemical Society. 
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Compared with ODNs and polymers, peptides could provide even more tunability 
in surface functions and properties. Wide selection of the side chains of natural and 
unnatural amino acids could satisfy a variety of chemical and biological purposes. 
Moreover, different combinations of peptides could be deposited simultaneously in gold 
colloids to yield a library of multifunctional gold nanoparticles for further screening for 
specific functions [20, 24]. 
This chapter reports the proof-of-principle study on a combinatorial approach to 
prepare a library of biodegradable nanoshells (Figure 4.2). The nanoshells were prepared 
by crosslinking the peptide-modified gold nanoparticles and then removing the gold 
template. The resulting nanoshells were characterized and the future direction of this 
approach is discussed. With the promising preliminary result obtained in this chapter, we 
envision that this synthetic strategy can be a powerful tool for preparing biodegradable 
nanostructures for in vitro and in vivo delivery. 
 
 
Figure 4.2 Synthetic scheme for peptide nanoshells. Cationic peptides are 
first deposited on the gold nanoparticle template. The lysines in the 
peptide sequences are then crosslinked by a biodegradable crosslinker. 
The gold nanoparticle template is then dissolved by potassium cyanide. 
The resulting cationic peptide nanoshell can then be complexed with 
siRNA, DNA or DNA/PNA complex for transfection purposes. 
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4.2 Results and Discussion 
4.3.1 Synthesis of 8 nm Gold Nanoparticle Templates 
We synthesized the 8 nm gold nanoparticle template following a published 
procedure [25]. Briefly, a 3.5 nm seed was made by reducing chloroauric acid solution 
with sodium borohydride at room temperature in the presence of sodium tricitrate as 
capping agent. This seed was then added to a growth media containing cetyl 
trimethylammonium bromide (CTAB) as capping agent, ascorbic acid as reducing agent 
and chloroauric acid. The resulting nanoparticle was 8.1 ± 0.7 nm measured by 
transmission electron microscopy (TEM) (Figure 4.3) and 13.3 ± 3.7 nm measured by 
dynamic light scattering (DLS). The difference between the DLS measurement and the 
TEM measurement accounts for the bulky surfactant layer on the gold surface that 
increased the hydrodynamic diameter of the gold nanoparticle but was invisible under 
TEM. The 8 nm CTAB-AuNP was chosen as the template because 1) smaller 
nanoparticles particles (d < 100 nm) showed the best cell uptake properties with diameter 
around 50 nm being the optimal [26-30].  Peptide nanoshells formed on smaller templates 
are most likely to remain small enough once the gold cores are removed;  2) AuNPs 
smaller than 8 nm cannot be purified by centrifugation so the synthetic process will be 
less convenient. 
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Figure 4.3 TEM image of 8nm CTAB-AuNP templates 
 
4.3.2 Ligand Exchange with the Lysine-Rich Peptide on the Gold Template 
KKKKKKKKKKYYC was exchanged for citrate on the surface of the 
gold template to give K10Y2C-AuNP. Atomic force microscopy (AFM) showed 
a particle with a height of about 8 nm (Figure 4.4a) and the modulus channel 
(Figure 4.4b) showed that each particle consisted of a hard core measuring about 
14.2 ± 1.2 nm in diameter corresponding to the gold core and a donut-shaped 
outer layer around the hard core measuring 29.2 ± 1.2 nm in diameter 
corresponding to the peptide layer around the gold nanoparticle. The 
hydrodynamic diameter measured by dynamic light scattering is 10.9 ± 3.3 nm, 
indicating that the peptide layer was more tightly associated with the gold 
template than the CTAB layer. The difference between the measurement by 
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AFM and DLS could result from the different states that the K10Y2C-AuNP was 
in (dried on the mica vs in water) and the resolution limit of the AFM probe. The 
TEM image (Figure 4.5) showed that after peptide deposition, the colloid is 
more evenly dispersed than CTAB AuNP, indicating that the lysine rich peptides 
provide more effective repulsion among particles than CTAB. The average 
peptide loading of the K10Y2C-AuNP was 511peptide/AuNP. 
 
Figure 4.4 AFM images of K10Y2C-AuNP. a) Height image. b) Modulus 
image 
a) 
b) 
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Figure 4.5 TEM images of K10Y2C-AuNP. 
 
4.3.3 Crosslinking of the K10Y2C-AuNP 
K10Y2C-AuNP was crosslinked with sulfo-EGS (ethylene glycol 
bis[sulfosuccinimidylsuccinate]) (Figure 4.6) at peptide/crosslinker ratio of 1:1, 1:5, 
1:10, 1:30, 1:50 and 1:100. The surface plasmon resonances of the crosslinked AuNPs 
remained around 517 nm except for particles prepared with a 1:100 ratio, indicating that 
the colloid remained well dispersed without aggregation. At 1:100 peptide/crosslinker 
ratio, inter-particle crosslinking may have started to occur which would have changed the 
color of the colloid. DLS measurement confirmed that the crosslinked colloids were still 
well dispersed, with hydrodynamic diameters around 13 nm, except for the 1:100 ratio 
sample, whose hydrodynamic diameter increased to 40 ± 12 nm. However, both the AFM 
images (Figure 4.7) and the TEM images (Figure 4.8) showed that all the crosslinked 
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particles were less evenly distributed once they were dried on the imaging substrate than 
the non-crosslinked nanoparticles. This could be due to the fact that the amino groups 
that provide the inter-particle repulsion were transformed to much less basic amide 
groups to various degrees during the crosslinking process.  
 
 
Figure 4.6 a) Structure of the crosslinker sulfo-EGS (ethylene glycol 
bis[sulfosuccinimidylsuccinate]); b) The crosslinking reaction.  
a) 
b) 
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Figure 4.7 AFM modulus images of a) K10Y2C-AuNP crosslinked at 
peptide/crosslinker ratio of 1:1; b) K10Y2C-AuNP crosslinked at 
peptide/crosslinker ratio of 1:10. 
 
 
a) 
b) 
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Figure 4.8 TEM image of K10Y2C-AuNP crosslinked at 
peptide/crosslinker ratio of 1:10. 
 
4.3.4 Removal of the Gold Nanoparticle Template 
The gold nanoparticle core templates of the K10Y2C-AuNP crosslinked at 1:10, 
1:50 and 1:100 peptide/crosslinker ratios were dissolved by KCN and the DLS 
measurements of the resulting peptide nanoshells are shown in Figure 4.9. After the 
removal of the template, the hydrodynamic diameter of the crosslinked nanoshells 
increased from around 13 nm to around 40 nm (Table 4.1). No difference was observed 
in the nanoshells crosslinked at different peptide/crosslinker ratios. The non-crosslinked 
peptide-AuNP was treated with the same procedure and the product showed a very large 
diameter by DLS, indicating that no nanostructures were left after the gold template was 
removed. The difference in the diameters before and after gold removal is probably the 
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result of the repulsion between the positively charged peptide strands of the same 
nanoshell. The length of the crosslinker (16 Å) also allowed some flexibility in the 
nanoshell. 
 
Figure 4.9 Hydrodynamic diameter of CTAB-AuNP, K10Y2C-AuNP, 
crosslinked K10Y2C-AuNP before and after removal of the gold 
template.   
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Table 4.1 Hydrodynamic diameter of CTAB-AuNP, K10Y2C-AuNP, crosslinked 
K10Y2C-AuNP before and after removal of the gold template.  Error is the standard 
deviation of the size distribution. 
Particle Number mean 
diameter with gold 
(nm) 
Number mean 
diameter without gold 
(nm) 
K10Y2C-AuNP 10.9±3.3 736.4±196.7 
K10Y2C-X10-AuNP 12.5±3.5 34.6±19.6 
K10Y2C-X50-AuNP 14.3±4.3 41.1±13.0 
K10Y2C-X100-AuNP 40.2±12.1 37.2±10.1 
 
 
 
4.3.5 DNA Binding Affinity of the Crosslinked Peptide-AuNP and the Nanoshells 
ODN binding abilities of the peptide-AuNP crosslinked at 1:1, 1:10 and 1:30 
ratios before and after the removal of the gold template were evaluated by a gel 
retardation assay. Peptide-AuNPs and peptide nanoshells were mixed with 32P-labeled 
ODN in N/P ratios of 0, 2, 4, 16 and 32 and separated by native PAGE (Figure 4.10). 
Peptide K10Y2C alone was also tested as negative control. K10Y2C-AuNP showed 
relatively strong binding affinity. However, after only 20% of the lysines were 
crosslinked (K10Y2C-X1-Au), the binding affinity decreased dramatically. When all the 
lysines were crosslinked (K10Y2C-X10-Au and K10Y2C-X30-Au), the ODN binding 
affinity was completely lost. Interestingly, after the gold template was removed, all 
nanoshells including K10Y2C-X1 failed to bind ODN even at an N/P ratio of 32. The 
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peptide alone showed a completely different ODN binding pattern from that of peptide 
gold nanoparticles or nanoshells. 
 
Figure 4.10 Gel shift of ODN/gold nanoparticle complex and peptide nanoshell/gold 
complex at different N/P ratios. Lane 1 is ODN alone. Lane 29 is peptide/ODN complex.  
 
4.3 Conclusions 
In summary, we have demonstrated a novel method for synthesizing well-defined 
biodegradable nanoshells from crosslinking lysine-rich peptide, using AuNP as the 
template. Based on the design, the nanoshells are tunable in size by using AuNPs of 
different sizes; tunable in surface properties by depositing different peptides on the 
surface as discussed in Chapter 2; tunable in charge by altering the surface peptide and 
peptide-to-crosslinker ratio; and tunable in degradability through the use of different 
crosslinkers. This approach is also suitable for automated combinatorial applications. We 
envision that this general strategy can be applied to create a variety of complex and 
functional systems that are applicable in a broad range of disciplines.  
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4.4 Experimental 
Material All solvents and chemicals were purchased from Sigma-Aldrich and used 
without purification, unless otherwise indicated. Fmoc amino acids were purchased from 
AAPTEC. Fmoc-PAL-PEG-PS resin was purchased from Applied Biosystems. Sulfo-
EGS (Ethylene glycol bis[sulfosuccinimidylsuccinate]) was purchased from Thermo 
Scientific. The oligodeoxynucleotide d(TGTGACACACAGCGCTACAA) used in gel 
retardation assay were purchased from idtDNA and used directly without further 
purification. 
 
Measurements UV-Vis spectra were recorded on a Varian 100 UV-Vis spectrometer. 
Samples for transmission electron microscopy (TEM) measurements were prepared on 
Formvar/carbon coated copper grids. Micrographs were collected at 42,000× 
magnifications on a FEI Spirit Lab6 TEM. Dynamic light scattering (DLS) was measured 
on Malvern Nano Sizer. Measurements were taken at 25 ± 1 °C. Scattered light was 
collected at a fixed angle of 173°. The gold concentration of CTAB-AuNP colloid was 
determined on Perkin Elmer Elan DRC II ICP-MS using Bi as external reference. Atomic 
force microscopy (AFM) was done using quantitative nanomechanical mapping (QNM) 
on a MultiMode 8 scanning probe microscope (Bruker, Santa Barbara, CA) with NP-10 
gold probe (Bruker, Santa Barbara, CA) with the assistance of Matthew Hynes and 
Professor Joshua Maurer. Molecular structures were generated by MarvinSketch 
(ChemAxon). 
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Synthesis of K10Y2C The peptide were synthesized using standard solid phase automated 
Fmoc chemistry on a 6 µmol scale. After the synthesis, the Fmoc group on the amino 
terminus was removed by mixing 30 mg of resin with 1 mL 20% piperidine in DMF for 
30 min. The resin was then washed with 1 mL DMF four times and 1 mL of DCM once, 
then dried under nitrogen. A cleavage cocktail (440 µL of trifluoroacetic acid, 25 µL of 
water, 25 µL of phenol and 10 µL of triisopropylsilane) was added into the resin and the 
mixture was incubated under room temperature for 3 h. After the cleavage cocktail was 
separated from the resin, 1.2 mL of cold anhydrous diethyl either was added to the 
cleavage cocktail to precipitate the crude peptide. The resulting precipitate was collected 
by centrifugation and purified by reverse-phase HPLC on a Waters XBridge Prep C18 
column (130  Å) with buffer A (0.1% TFA in H2O) and buffer B (0.1% TFA in CH3CN) 
on a Beckman System Gold instrument equipped with a UV-vis array detector. The flow 
rate was 2.5 mL/min and the gradient was 1%/min starting from 5% buffer B. The 
fractions were collected and concentrated to dryness in a Savant SpeedVac and 
characterized by UV-vis and MALDI-TOF which was carried out on a PerSpective 
Voyager mass spectrometer with α-cyano-4-hydroxycinnamic acid as the matrix and 
insulin as the internal reference. MALDI: exact (M+H)+ expected: 2085.4, found 2085.2. 
 
Synthesis of CTAB-AuNP A 20 mL aqueous solution containing 2.5 × 10-4 M HAuCl4 and 
2.5 × 10-4 M trisodium citrate was prepared in a conical flask. Next, 0.6 mL of ice-cold, 
freshly prepared 0.1 M NaBH4 solution was added to the solution while stirring. The 
solution turned orange immediately after adding NaBH4, indicating particle formation. 
The particles in this solution were used as seeds within 1-2 h after preparation. A 200 mL 
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aqueous solution of 2.5 × 10-4 M HAuCl4 was prepared in a conical flask. Next, 6 g of 
solid cetyltrimethylammonium bromide (0.08 M final concentration) was added to the 
solution, and the mixture was slightly heated until the solution turned into a clear yellow 
color. The solution was cooled to room temperature and used as a stock growth solution. 
90 mL of growth solution and 0.5 mL of 0.1 M ascorbic acid solution were mixed, and 10 
mL of seed solution was added while vigorously stirring. After stirring continued for an 
additional 10 min the solution developed a deep red color. The resulting particles were 
centrifuged at 40 oC, 126,000 rcf for 30 min. The pellet was separated and re-dispersed in 
double distilled water and centrifuged again. This procedure was repeated twice. Finally, 
the colloid was re-dispersed in double distilled water and stored under 4oC in the dark. 
 
Determination of the extinction coefficient of CTAB-AuNP 10 µL of CTAB-AuNP colloid 
was dissolved in 90 µL of concentrated nitric acid and then dilute 100, 1000 and 10000 
times with 1% nitric acid. The standard solutions was prepared with HAuCl4 standard 
(Perkin Elmer) at 0.1, 0.5, 1, 5, 10 and 100 µg/L in 1% nitric acid. The gold concentration 
was measured on Perkin Elmer Elan DRC II ICP-MS using Bi as external reference. 
Another series of CTAB-AuNP colloid was diluted by 2, 2.5, 3.3, 5, and 10 times in 
double distilled water. The absorbance of the diluted colloid at 517nm was measured and 
plotted against corresponding concentration. The extinction coefficient was calculated 
from linear regression. 
 
Synthesis of K10Y2C-AuNP K10Y2C (5 µL of 44.2 mM solution) was mixed with 5 µL 
of 50 mM TCEP followed by addition of 1 mL of 29.3 nM CTAB-AuNP and then 
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incubated at room temperature. NaCl (50 µL of 2M solution) was added to the mixture 
every 20 min until the final concentration of NaCl reached 0.3 M. The mixture was then 
allowed to incubate under room temperature in the dark overnight. To remove the 
unreacted peptide, the colloid was centrifuged at 126,000 rcf for 30 min. The supernatant 
was removed. The pellet was re-dispersed in double distilled water.  This process was 
repeated twice. The final concentration was determined by absorbance at 520 nm (λmax) 
using the extinction coefficient of CTAB-AuNP. To determine the peptide loading, 30 µL 
of K10Y2C-AuNP was dried in a Savant Speedvac and then dissolved in 3 µL of 100 
mM KCN (CAUTION: HIGHLY TOXIC). The absorbance of the resulting solution was 
measured at 277 nm on NanoPhotometer (Implen) and the concentration was calculated 
according to the extinction coefficient of tyrosine. 
 
Crosslinking of K10Y2C-AuNP Sulfo-EGS (Ethylene glycol 
bis[sulfosuccinimidylsuccinate]) 3.75, 18.75, and 37.5 µL of 2 mM solution was added to 
K10Y2C-AuNP (final concentration: 10 nM, final volume: 100 µL) for K10Y2C-X10-
AuNP, K10Y2C-X50-AuNP and K10Y2C-X100-AuNP. The mixture was shaken at 
room temperature overnight. The resulting colloids were dialyzed against 1 L of double 
distilled water in mini Slide-A-Lyer (MWCO 10,000) for 2 h. 
 
Removal of the gold template KCN (10 µL of 100 mM solution, CAUTION: HIGHLY 
TOXIC) was added to 100 µL of 10 nM crosslinked peptide gold nanoparticle. The 
mixture was incubated at room temperature for 1 h (when the red color disappeared). The 
hydrodynamic diameter of the peptide nanoshells was quickly measured by DLS. The 
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nanoshells were then dialyzed in 100 µL Slide-A-Lyzer dialysis cup (MWCO: 10,000) 
against double distilled water for 1 h. The volume of the final colloid was measured and 
the concentration of the nanoshell was calculated according to the concentration of the 
crosslinked gold nanoparticle. 
 
 Gel retardation assay The oligodeoxynucleotide d(TGTGACACACAGCGCTACAA) 
was 5’-labeled with [ϒ-32p-ATP] with T4 polynucleotide kinase. Serially diluted 
amounts of peptide gold nanoparticles and peptide nanoshells were mixed with 50 nM 
radiolabeled OND at N/P ratio indicated in Figure 4.9 in 10 mM Tris pH 7.5 buffer with 
50 mM NaCl for 30 min. The mixtures (20 µL) were then mixed with 5 µL of 50% 
glycerol and 5 µL of the final mixtures were loaded to 10% native polyamide gel. 
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Chapter 5 
Concluding Remarks and Future Work!
Despite of the increasing interest in biomolecule-functionalized nanoparticles, 
many challenges still remain unsolved. There has always been a compromise between 
structural definedness and tunability, transfection efficacy and cytotoxicity, stability and 
biodegradability, etc,. 
This dissertation has addressed some of the challenges with novel approaches for 
nanoparticle design and preparation. In Chapter 2 a DNA hybridization-based self-
assembling nanoparticle system was developed, which is both highly well defined and 
tunable. The tunability was demonstrated through the ready assembly between 
oligodeoxynucleotide-protected gold nanoparticles (ODNAuNP) and functionalized 
peptide nucleic acids (PNA). The resulting nanoparticles were highly stable in vivo, as 
shown by bio-distribution in mice. The surface PEGylation also successfully reduced 
non-specific cell uptake. With PEGylation, most of the nanoparticles were still cleared 
within one hour from the blood circulation and remained in the liver. These initial results 
paved the road for further development as nanoparticle-based imaging and therapeutic 
agents. In future studies, more functions could be assembled in the same manner. First, to 
extend the number of accessible sites for functionalization, one or more layers of 
branched ODN or PNA can be assembled on the ODNAuNP. By adjusting the length of 
each branch, the ligand geometry on the gold surface can be controlled. For example, 
with a longer ODN-binding stem, the ligands hybridized on the branches could be farther 
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apart from one another and hence allow more space for bulky ligands such as PEG or 
protein. With two shorter branches, the ligands attached to the same branched PNA or 
ODN could be closer than they are from other PNA or ODN. If the sequences on the two 
branches are different, two different ligands could be precisely hybridized on each branch. 
The short distance between these two ligands could facilitate cooperative functionalities. 
(Figure 5.1).  
 
Figure 5.1 Illustration of branched PNA or ODN assembled on the ODN-
AuNP. The black lines represent the ODN attached on the gold surface. 
The stems (blue lines) and branches (red lines and green lines) could be 
different in length and sequence.  
 
Secondly, the bio-distribution pattern shown in Chapter 2 is very promising for 
liver targeting. However, the blood retention of the nanoparticles needs to be significantly 
improved for targeting other organs via systematic administration. For nanoparticles with 
a given size, there are two ways to improve circulation: increase the surface density of the 
passivation ligand, i.e. increase of the loading or the size of the passivation ligand, or use 
a different type of passivation ligand.  In our case, longer and more branched PEG can be 
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used in the place of PNA-(PEG2K)3. More PEG can also be loaded if the ODN-AuNP is 
derivatized by the branched ODN/PNA mentioned above. Besides PEG, A variety of 
natural polymers such as heparin, dextran, and chitosan, along with many synthetic 
polymers have also been used in a wide range of drug-delivery systems [1, 2]. These 
alternatives might provide us opportunities to improve the circulation of gold 
nanaoparticles. 
Once the blood retention is increased, targeted delivery would become possible. 
Targeting moieties such as antibodies, aptamers, peptides, or other small molecules can 
be conjugated to peptide nucleic acids and assembled on the ODNAuNP. The linker 
between the targeting ligand and PNA can be adjusted to avoid loss of activity caused by 
PNA interference. If two factors are needed for a particular binding process, they can be 
hybridized onto one branched PNA or ODN so that the adjacency is ensured. 
The nature of DNA hybridization provides another advantage of this approach. 
The ODN sequence could be designed to be partially complementary to the PNA 
sequence and completely complementary to the target mRNA or DNA. Once the 
nanoparticle enters the desired cell, the PNA-payload conjugate could be displaced by the 
target mRNA and function independently of the nanoparticle. Mirkin et al. reported a 
similar approach, where EGFP antisense ODN was hybridized on an ODNAuNP. Once 
inside the cell, EGFP antisense ODN was displaced and hybridized with EGFP mRNA to 
knockdown the expression of EGFP [3]. When a fluorescent dye is used as payload, this 
system can be used for in vivo mRNA imaging. Mirkin’s group reported a study on in 
vitro mRNA imaging using this strategy. Fluorescently labeled ODN was hybridized with 
ODNAuNP. The dye was quenched by the gold nanoparticle. When the nanoparticle 
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comes in contact with the target mRNA, the fluorescent ODN was displaced and become 
fluorescent. The complementary-probe-treated cell line with target mRNA showed much 
higher fluorescence than the control cell line or non-complementary-probe-treated target 
cell line [4]. This type of system could be applied in vivo using the design described in 
Chapter 2.  
The accuracy of DNA hybridization could be better taken advantage of by 
attaching several ODN sequences simultaneously on one gold nanoparticle. Different 
functional ligands could be conjugated to the different antisense PNAs and hybridized 
simultaneously on the ODN-AuNP. In this way, the composition of the ligands on the 
gold surface could be more precisely controlled. 
In Chapter 3, a series of arginine-rich peptide functionalized gold nanoparticles 
were synthesized by reducing goldIII with sodium borohydride. The resulting cationic 
gold nanoparticles (cAuNPs) exhibited excellent stability in high salt solution and broad 
pH range, which makes them suitable for biological applications. Due to the high affinity 
between guanidinium group and phosphate group, the arginine-rich gold nanoparticles 
showed very high ODN binding constant on the gel shift assay. Unlike the individual 
oligoarginine peptides, the arginine-rich gold nanoparticles didn’t exhibit any 
cytotoxicity even at high concentration. With the knowledge gained in the cAuNP study, 
a better and more universal synthetic strategy was proposed. Cationic peptides syntheized 
by combinatorial peptide synthesizer were deposited directly on gold nanoparticles 
synthesized by citrate reduction or seeded growth method. Nanoparticles fabricated this 
way retained the morphology and monodispersity of the original gold colloid and yet 
showed distinct properties consistent with their surface composition. For proof-of-
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principle study, three peptide-AuNPs were synthesized based on CTAB protected gold 
nanoparticles, R13C-AuNP, K10Y2C-AuNP and R13C/K10Y2C-AuNP.  The R13C-
AuNP behaved the same as R13C-AuNP synthesized by NaBH4 reduction, which bound 
to ODN effectively but aggregated in phosphate buffer at higher pH reversibly. The 
K10Y2C-AuNP, however, was stable in a broader range of buffers and pH’s but a much 
weaker ODN binder. The combination of K10Y2C and R13C on R13C/K10Y2C-AuNP 
resulted in intermediate ODN binding ability and buffer stability. This approach indicated 
a possibility of quickly assembling a library of peptide-AuNPs whose functions could be 
easily tuned by altering the peptide sequences by use of a combinatorial automated 
peptide synthesizer. Although none of the peptide-AuNP tested in this study effectively 
transfected pLuc705 HeLa cells in the splice correction assay, I believe that the 
transfection ability could be optimized by changing the peptide composition and 
sequence.  
Based on the combinatorial synthesis described in Chapter 3, a biodegradable 
peptide nanoshell was synthesized by crosslinking the lysine-rich peptide on the gold 
nanoparticle and then removing the gold template. As a proof-of-principle study, only 
one peptide-AuNP, K10Y2C-AuNP was synthesized with different extents of 
crosslinking. DLS showed that after the gold template was removed, the nanoshells 
remained assembled, although the hydrodynamic diameter of the nanoshells increased by 
around 20 nm, probably due to the electron static repulsion between the oligolysine 
strands and the length of the crosslinker (~16 Å). The crosslinking, however, caused a 
dramatic decrease in the ODN binding ability, even at low crosslinking ratios, indicating 
that the number of amines on the surface is much more important than the number of total 
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amines. Based on this preliminary data, several optimizations could be envisioned for the 
future. To improve the ODN binding ability, arginines could be added to the peptide 
strand between the lysines and the cysteine. When the gold template is removed, the 
arginines would be exposed and available for ODN binding and cell entry. To better 
regulate the size of the nanoshell, other crosslinking strategies could also be employed. 
Dash et al. reported a hollow sphere crosslinked by microbial transglutaminase (mTGase). 
In their study, Elastin-like polypeptide was assembled electrostatically on polystyrene 
(PS) beads of different sizes. Then mTGase was used to crosslink between lysines and 
glutamines. The resulting nanostructure was robust and remained spherical even after the 
PS bead was dissolved by THF [5]. Their approach, however, allows less tunability in 
peptide functions due to the amorphic assembly on the template surface.  
Once the nanoshell is formed, there are several ways to encapsulate the payload, 
besides the electrostatic association mentioned in Chapter 4. During the dissolution of 
the gold templates, the thiol group on the cysteine will be exposed. Payloads 
functionalized with thiol reacting groups such as maleimide and bromo acetyl could be 
covalently conjugate to the nanoshell. If the payloads are functionalized with thiol groups, 
they can form disulfide bonds with the nanoshell and be released inside the endosomes. 
Payloads functionalized with multiple thiol groups could further stabilize the nanoshell 
structure as well. pH-responsive peptides could be incorporated into the nanoshell. For 
example, at lower pH, the peptides are protonated and repel from one another. The 
nanoshell will be “open” and the payload can enter the hollow center. Then when the pH 
is higher, the peptides would be neutral and more hydrophobic and the hydrophilic 
payload would be trapped inside the nanoshell. Once the complex enters the cell via 
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endocytosis, as the pH in the endosome decreases, the nanoshell would be “open” again 
and release the payload. In future cell studies, targeting peptide or endosomal escape 
peptides could also be incorporated in the nanoshell to facilitate diagnostic or therapeutic 
purposes. To take a step forward, the stealth design that was used in the ODN-AuNP 
study could be applied to the nanoshell in vivo. 
Biomolecule modified nanoparticles have great potential in many biomedical 
applications. Although a lot of interesting work has been conducted, further research 
must be continued in this area to realize the full potential of these nanoscale materials. 
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